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This report is intended to serve as a review of the implications for food safety of the application of
nanotechnology in food production and processing as they relate to Ireland. The report does not
purport to be comprehensive or to be a legal interpretation or to constitute legal or other
professional advice.Advances in scientific knowledge and changes in legislation can be expected in the
future that will necessitate the updating of this report.
Literature and research cited in the report are valid, to the best knowledge of the authors, at the time
of publication. Reference in this report to any trade names, commercial products, process, service,
manufacturer, organisation or company does not constitute its endorsement or recommendation by
the Food Safety Authority of Ireland (FSAI). Examples contained in this report are not exhaustive and
are intended for illustration purposes only.The FSAI is not responsible for the contents of any website
referenced in this report. Unless otherwise stated, the definitions and terminology used in this report
relate to this report only.
DISCLAIMER
F OO D S A F E T Y AU T H O R I T Y O F I R E L A N D
2
The application of nanotechnology in the food and feed industry offers many potential benefits for
both consumers and manufacturers.The ultrafine dimensions of nanoparticles, and consequently their
very large surface area, enable them to function more effectively than conventional macro-scale
structures in many applications. Nanotechnology is however a relatively new area of science and the
benefits and risks associated with its use in the food and feed industry are not fully understood at this
time.This brings with it new challenges in ensuring the safety of food and feed that has been produced
with the aid of nanotechnology.
This report provides an overview of current and potential applications of nanotechnology in the food
industry, which may equally be applied in the feed industry. The possible risks of nanotechnology,
together with the adequacy of the existing EU regulatory framework in the control of any potential
risks, are also examined with a view to determining what further legislative measures, if any, may be
necessary to safeguard food safety.
This report notes that nanoparticles are already naturally present in food, given that many food and
feed ingredients are comprised of endogenous proteins, carbohydrates and fats with sizes extending
from large biopolymers (macromolecules) down to the nanoscale.The applications of nanotechnology
in food production reviewed in this report must therefore be viewed in the context of this
background exposure to natural nanoparticles in the diet.
There is currently no known use of nanoparticles in food on the Irish market, although such foods are
known to be available on the global market, mainly through internet trading.This report demonstrates,
however, that nanotechnology has the potential to have a major impact on food innovation over the
coming decades.The application of nanotechnology to enhance the stability and texture of food and
to develop “intelligent” food contact materials, including packaging, is currently of considerable
interest to the food technology sector.The controlled release of nano-encapsulated food ingredients
or nutrients is likely to be a primary focus in the longer term as the technology evolves.
There are some knowledge gaps regarding the potential for nanoparticles present in food and feed to
enter parts of the body hitherto inaccessible to their conventional counterparts. Evidence is
accumulating that engineered nanoparticles can cross natural barriers within the body, although the
health implications of this, if any, are as yet unclear and have to be put in context with the background
exposure to nanoparticles found naturally in food.There is an urgent need to develop predictive and
validated toxicological tests that can be used to screen for potential hazards, and also to develop new
methodology for the measurement of nanoparticles in biological matrices, in order to assess human
exposure. Nanoscale proteins, carbohydrates and fats are unlikely to be a source of toxicity in their
own right. However, little is known about possible interactions of such nanoparticles with other food
components, the integrity of the nanoparticles following passage through the digestive system or how
they are absorbed, distributed and excreted (cleared) from the body.
EXECUTIVE SUMMARY
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Although the basic principles of the conventional risk assessment model can be applied to nano-
based food, in practice, gaps in the knowledge base make it difficult to carry out a meaningful risk
assessment. Until such time as these knowledge gaps are filled and there is international agreement
on the approaches to assessing the risks, each application of nanotechnology in food production, and
the wider implications of nanotechnology for the food chain, will need to be assessed on a case by
case basis. Hence, risk management approaches to foods resulting from nanotechnology will, because
of necessity, be precautionary.
The existing EU legislative food safety framework does not contain specific provisions on
nanomaterials. However, uses of nanotechnology in food are considered to fall within the scope of
general food law, in that the food sector is obliged to only place safe food on the market, or are subject
to specific approval processes such as those for food additives, food contact materials, novel foods,
pesticide and biocide approval systems. Specific controls on the use of nanotechnology in food
production are being incorporated in pending EU legislation that will see the European Food Safety
Authority (EFSA) being responsible for the safety assessment of nanoscale additives and ingredients.
An important principle highlighted in this report is that the food business operator is primarily
responsible for ensuring the safety of food. However, it is acknowledged that the assessment of
possible risks and likely exposure patterns of nanofoods is not clear cut, given that current
methodologies may be inadequate in identifying hazards and evaluating risks associated with the
specific properties of nanoscale substances.
Reflecting the deficiencies in the available information on the current applications of nanotechnology
in the agrifood sector and also the information needed to carry out a meaningful risk assessment; this
report contains a number of recommendations, including the following:
• food business operators should conduct risk assessments on all foods involving introduction
of new nanoparticles into foods and packaging or manipulation of the size distribution of
natural food molecules in food matrices, in order to meet their legal obligations to produce
safe food
• legal provisions should be considered at EU level to ensure that food and feed should be re-
evaluated in terms of safety whenever the properties are changed/re-engineered to the
nanoscale
• the FSAI should promote the establishment of a publicly available inventory of
nanotechnology-based food products and food contact materials, both at European
Community level and specifically available on the Irish market 
F OO D S A F E T Y AU T H O R I T Y O F I R E L A N D
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• urgent consideration should be given to whether additional controls are required on the
disposal and/or recycling of nanoparticle-containing food contact and other materials
• food surveillance programmes should include investigation of the potential for nanoparticles,
particularly inorganic molecules such as titanium dioxide and clay particles used in packaging,
to migrate into foods and also to be recycled in the environment and enter the food chain
indirectly.
In addition, in order to protect and inform consumers, the report proposes that food or food
packaging in contact with food and incorporating nanoparticles should be labelled, and that the FSAI
should keep Irish industry informed of developments concerning the applications of nanotechnology
in food and the legal requirements governing such uses.The report also recommends that the FSAI
should keep under review advances in the science of nanotechnology, risk assessment approaches and
the legal framework governing the application of nanotechnology in food.
Finally, the report stresses that appropriately funded research should urgently be undertaken to
increase the reliability of the assessment of possible risks of nanotechnology in food, including on
issues such as the fate and behaviour of nanoparticles within the human body and animals; their
potential toxicity; methods for the safe and effective disposal of used or waste nanoparticles; the
stability/lability of nanoparticles in various foods and their potential interactions with other food
components.
Keywords: Nanoparticles, nanomaterials, nanotechnology, food, nanofood, nanotoxicology
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1.1 Background
The last decade has seen an explosion of interest in the applications of nanotechnology in a wide
range of areas including food production.The commercial application of nanotechnology is however
currently much more advanced in areas other than food, such as materials science, electronics and
medicine. Many possible food applications are at a research stage in academia and industry, but at
present, the full potential for such products has not been realised. Only a small number of products
have actually been commercialised, mainly in countries outside the EU, the US being the leader in
innovation in this field, followed by Japan and China. A recent report identified a wide range of
applications in food and food technology, and suggested that the value of the worldwide
nanotechology food market may total $20.4 billion (€19.4 billion) by 2010 and $1 trillion (€740bn)
by 2013 (Kaiser, 2007).
The principal areas in the food sector where nanotechnology has potential for use are in
encapsulation and emulsion formation, in food contact materials and sensor development, and some
applications of the technology are close to utilisation. For instance, in 2007, the European Food Safety
Authority (EFSA) published an opinion on the safety of a nanoscale silicon dioxide coating (less than
100 nanometre), to be used in plastic packaging behind an inner layer of polyethylene terephthalate
(PET) plastic to provide gas barrier properties (EFSA, 2007). In addition, a safety evaluation for a
titanium nitride-based nanoparticle to be used as a food contact material additive is currently being
undertaken by EFSA. Other possible applications are explored in more detail in Chapter 2 of this
report.
Application of nanotechnology in the agrifood sector, and more generally, offers potentially huge
benefits for both consumers and manufacturers in a wide range of applications, and research in the
area is attracting increasing investment from Governments and industry worldwide. Many of these
benefits result from the ultrafine dimensions of nanoparticles, which enable them to reach new
locations in the body, or from their very large surface area which enables them to function more
effectively than larger scale materials, an example being the use of nanosilver as an antimicrobial agent
in food contact materials.
While it is recognised that emerging nanotechnology applications are likely to bring significant
benefits, it is also recognised that nanomaterials may present different hazards from those of the same
material in a micro or macro form. There is concern that not enough is known about the
toxicological/physiological and environmental effects of such materials, and that current risk
assessment methodology may not be adequate to identify the risks for man and the environment,
including animal health.This is discussed in more detail in Chapter 4 of this report.
1. INTRODUCTION
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Judging by the public response to genetically modified (GM) technology in both food and animal feed,
the use of nanotechnology in food production is likely to be one of the more contentious areas of
application, and the safety of consumers exposed to nanoparticles through food must be assured. In a
recent survey of 1,000 German consumers commissioned by the Federal Institute for Risk Assessment
(BfR, 2008), although 66% of respondents believed that the overall benefits of nanotechnology
outweigh the risks and only 9% considered that the reverse was true, the majority of respondents
were against the use of nanotechnology in food. Only 4% considered that the benefits of application
of nanotechology in food outweighed the risks, while 84% did not want enhancement of the
appearance of food by the use of nanoparticles.A UK consumer organisation conducted a survey of
public perception of nanotechnology in a “Citizen’s Panel” of seven men and seven women, over a
period of three days. They found that overall consumers were positive about the benefits of
nanotechnology, but opinions differed in relation to the application in food production and
manufacturing (Which?, 2008).The UK consumer group surveyed considered that the tightest controls
were required with regard to applications of nanotechnology in medicine and food, as these are areas
where nanoparticles may be ingested, and were more positive about the potential for
nanotechnologies in food packaging. A survey of Swiss consumers has indicated that consumers are
more concerned about food produced by application of nanotechnology than about food packaging
containing nanoparticles (Siegrist et al., 2008) 
A number of expert bodies have already issued opinions on issues related to applications of
nanotechnology and its safety, including the European Commission’s Scientific Committee on
Emerging and Newly Identified Health Risks (SCENIHR) (SCENIHR, 2006, 2007), the EU Scientific
Committee on Consumer Products (SCCP) (SCCP, 2007), the US Food and Drug Administration (US
FDA) (FDA, 2007), the UK Committees on Toxicity, Mutagenicity and Carcinogenicity of Chemicals in
Food, Consumer Products and the Environment (COT, COM, COC) (COT, 2005), the UK Royal
Society and Royal Academy of Engineering (Royal Society and Royal Academy of Engineering, 2004),
the German Federal Institute for Risk Assessment (BfR, 2007), the Dutch Institute of Food Safety,
Wageningen UR (RIKILT) and National Institute of Public Health and the Environment; Center for
substances and integrated risk assessment (RIVM) (Bouwmeester et al., 2007) and the US National
Institute of Occupational Health (NIOSH) (NIOSH, 2007). An EFSA opinion on the risks of
nanoparticles in food is expected in 2008 and food safety agencies throughout the world are currently
assessing the issue.
In April 2007, the Food Safety Authority of Ireland’s (FSAI) Scientific Committee discussed the national
need for a scientific assessment of the relevance/implications of the application of nanotechnology in
food production and processing for food safety.An expert working group (Appendix 1) was convened
in June 2007 to further consider the issues, with the aim of developing a position on nanotechnology
in relation to food safety and risks to the Irish consumer.
F OO D S A F E T Y AU T H O R I T Y O F I R E L A N D
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1.2 Terms of Reference
The Terms of Reference for the Scientific Advisory Working Group on Nanotechnology were as
follows:
• advise on the main applications of nanotechnology foreseen in food and animal feed
• advise on the adequacy of current risk assessment paradigms/methodology for the
identification, assessment and control of any potential risks arising from the use of
nanotechnologies in the agrifood sector or the presence of nanoparticles in food
• identify gaps in the regulatory framework and information needed to carry out an assessment
of risk of nanoparticles in the food chain 
• advise on approaches to fill such gaps
• advise the FSAI on the development of a national position on nanotechnology in relation to
food safety and risks to the Irish consumer
• support the FSAI in the drafting of a report to reflect these issues, for the approval of the
Scientific Committee.
1.3 Scope of the Report 
The Terms of Reference apply primarily to the application of nanotechnology in food production and
processing and the implications for the safety of food, the term “food” being defined in accordance
with Regulation (EC) No 178/2002 on general food law (EC, 2002), as follows:
“Food or foodstuff1 means any substance or product, whether processed, partially processed or
unprocessed, intended to be, or reasonably expected to be ingested by humans. For the purpose of this
report, drinking water is included under the definition of food.”
The presence of nanoparticles in the food chain as a result of environmental contamination and
accidental or deliberate inclusion of nanomaterials in animal feed may be an additional, indirect route
of human exposure via food, in addition to the direct use of nanomaterials in the production and/or
processing of food for humans. Accordingly, this report has also briefly considered the use of
nanotechnology in the production of feed for food-producing animals and also potential pathways of
nanoparticles from the environment into food.
Consideration of direct human exposure via the environment, other than the food chain, and via
occupational exposure is outside the scope of the report.
1 Food includes drink, chewing gum and any substance, including water, intentionally incorporated into the food during its
manufacture, preparation or treatment. It includes water after the point of compliance as defined in Article 6 of Directive
98/83/EC and without prejudice to the requirements of Directives 80/778/EEC and 98/83/EC.
F OO D S A F E T Y AU T H O R I T Y O F I R E L A N D
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1.4 Definitions of Nanotechnology Applied in this Report
The term ‘nanotechnology’ was first applied in 1974 by Norio Taniguchi (Taniguchi, 1974) and was used
to describe production technology at ultrafine dimensions, hence the use of the Greek word ‘nano’ -
meaning dwarf. Nanotechnology has now evolved into a multidisciplinary research sector with a
rapidly expanding industrial element. Likewise, the terminology has also evolved and grown to reflect
the diversity of this area of science and technology with numerous broad definitions of
nanotechnology emerging from a variety of professional, national and international bodies.
The International Standards Organization (ISO) recognised that there is a need to standardise
terminology and provide a common language for scientific, technical, commercial and regulatory
purposes.The ISO/TC229 Technical Committee on Nanotechnologies established a working group to
advise on this specific issue and, although work is still ongoing, the following general definition for
nanotechnology has emerged from the group:
‘Understanding and control of matter and processes at the nanoscale, typically, but not exclusively,
below 100 nanometres in one or more dimensions where the onset of size-dependent phenomena usually
enables novel applications, where one nanometre is one thousand millionth of a metre.’
(ISO/TC 229, 2008).
This definition is non-specific and can be applied across the entire nanotechnology community from
academia to industry. It has therefore been adopted in this report as a basic definition of
nanotechnology in the absence, at the time of writing, of any internationally agreed definition.
However, it is important to note that the definition makes no reference to the synthesis or use of
engineered nanomaterials in food or feed products. For the purpose of clarity throughout the report,
it should be taken that an engineered nanomaterial is any material which has been intentionally
synthesised or incidentally produced to exploit novel functional properties exhibited on the nanoscale
(i.e. typically, but not exclusively, below 100 nanometres in one or more dimensions as specified by the
ISO definition).
In contrast, the generic term of 'nano-object' as defined by the EU Commission recommendation of
07/02/2008 on a code of conduct for responsible nanosciences and nanotechnologies research (EC,
2008) will include all nanomaterials, nanostructured materials, nanoparticles and their aggregation at
the nanoscale, nano-systems, and nanoproducts.
F OO D S A F E T Y AU T H O R I T Y O F I R E L A N D
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2.1 Introduction
Given that most food systems are comprised of biopolymers with a range of particle sizes including
some with nanoscale dimensions, nanotechnology is not a novel concept in food science.The specific
applications of the technology are however rapidly increasing and are expected to have a major impact
on food innovation over the coming decades.A number of reviews which describe the application of
nanotechnology in the food sector have been published, e.g. Chen et al., 2006a; Chaudhry, 2008; ETC
group, 2004; Miller and Senjen, 2008; Morris, 2005; Morris, 2006.This chapter identifies the key areas
where applications of nanotechnology are being researched or have already been introduced in the
agrifood sector.
A wide range of applications are foreseen in the agrifood sector, including nanosensors, tracking
devices, targeted delivery of specific components, food safety applications, new product development,
precision processing and smart packaging. The potential applications of nanotechnology range from
modifications of the natural (organic) protein, carbohydrate and fat molecules that form part of the
normal diet, to achieve added or altered functionality, to the use of inorganic nanoparticulate materials
in food packaging and food ingredients including food additives.The predominant food-related use of
nanoscience in the short term is in food contact materials including packaging, while in the longer
term nanoscale food research appears to be focused on controlled release of nanoscale-encapsulated
food ingredients or nutrients. The use of nanoscale technologies for alteration of food stability and
texture is also of particular interest.
Engineered organic nanomaterials (primarily nanoparticulate forms of natural food components) are
likely to be the predominant area of interest in the agrifood sector. Many applications of
nanotechnology currently under research involve modification of the normal structure and assembly
of natural biopolymeric food components, e.g. modification of proteins or selected carbohydrates to
make them suitable as nanostabilisers of bioactive components. Protein-carbohydrate engineering
coupled with enzymatic functionalisation is being used to construct nanoscale structures which impart
new functionality in food.
Nanoparticles in food will be exposed to a range of storage and use conditions, and this is an aspect
that may need consideration in relation to assessment of the impact of nanotechnology in the agrifood
sector. For example, nanoparticles may be used in products that should be stored at low temperatures
and then heated for consumption.This may affect both the nanoparticle stability within the food, as
well as changing the properties of the biomolecules in the food, and potentially how these interact
with the nanoparticles.To date, there appears to be no literature dealing with this.
Figure 2.1 summarises the main areas where nanotechnology is currently used in food and where food
safety issues may arise.
2. CURRENT AND POTENTIAL APPLICATIONS 
OF NANOTECHNOLOGY IN THE FOOD CHAIN
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Figure 2.1 Applications of Nanotechnology in Food
2.2 Current Applications of Nanotechnology in Foods and Food Contact
Materials
Some of the benefits of nanoscience have already been seen in the agrifood sector2, others are still at
the research and concept stage.They include the following global applications:
1) sensory improvements (flavour/colour enhancement, texture modification) 
2) increased absorption and targeted delivery of nutrients and bioactive compounds 
3) stabilisation of active ingredients such as nutraceuticals in food matrices 
4) packaging and product innovation to extend shelf-life 
5) sensors to improve food safety
6) antimicrobials to kill pathogenic bacteria in food.
Nanotechnology-based materials of relevance to food and food contact materials include
nanoparticles, nanofibres/fibrils, nanoemulsions/dispersions and nanoclays, as summarised in Table 2.2.
Each category is explained in more detail below.
Food/Beverage
(Consumer; Medical; Research)
Technologies
(Nanoemulsions; Nanodispersions;
Nanoencapsulation; Self assembly)
Nanotechnology
and
Food Safety
Packaging
(Smart packaging; Nanolaminates;
antimicrobial)
Processing
(Reaction kinetics;Thermal,
separation &
Dehydration technologies)
Stability/Shelf-life
(Nanotracers;
Nanosensors/Biosensers)
Ingredients
(Nanoparticles; Nanostuctured
biopolymers; Nanopowders;
Nanocapsules)
2 It should be noted that the applications listed reflect international use, and there is no clear picture of which, if any, of these
applications relate to food available on the European or Irish markets.
F OO D S A F E T Y AU T H O R I T Y O F I R E L A N D
11
Table 2.2 provides a non-exhaustive list of examples of products currently on the international market,
resulting from the applications of nanotechnology in food.
Table 2.1  Classification of Nanomaterials with Application in Food and Food
Preparation 
Category Example Materials Example Application 
1. Nanoparticles
Inorganic Iron Food supplement
Silver Food supplements, antimicrobial agent
- used in food contact surfaces
(cutlery, storage containers, fridges and
worktops)
Iridium Food supplement
Platinuim Food supplement
Zinc Food supplement/colourant
Organic Liposomes Encapsulation and targeted delivery of
food components
Protein Re-micellised calcium caseinate from
dairy protein. Increased functionality
(gelation, heat stability and other
properties)
Polymeric Non-degradable: polystyrene
Biodegradable: PGLA, gelatin, collagen
2. Nanofibres*/fibrils
Globular proteins Thermal stability, increased shelf-life.
Formation of transparent gel network
for use as thickening agent 
3. Nanoemulsions/
dispersions
Emulsions Oil in water Stabilisation of biologically active
ingredients; delivery of active
compounds; extended shelf-life;
flavour release; low fat products
Dispersions Calcium Carbonate Increased solubility of calcium
carbonate – can be used at higher
addition levels
4. Nanoclays
Clay composites Used in packaging materials to extend
shelf-life, durability, and thermal
properties (includes nano-laminates)
* Nanofibres are not currently used in the marketplace but are being researched extensively.
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2.2.1 Nanoparticles 
Nanoparticles can be categorised into different types based on their ability to carry different
ingredients and react to different environmental conditions. For the purposes of this review they can
be divided into two broad categories, inorganic and organic, based on the chemical characteristics of
the nanoparticle. Nanoparticles already reported to be incorporated into foods (although not on
specifically on the EU market) include those engineered to provide encapsulation systems, e.g.
micelles, liposomes, for delivery of food ingredients, and those tailored for use in food packaging such
as biosensors, identification markers, shelf-life extenders and antimicrobials.
2.2.1.1  Inorganic nanoparticles
Many inorganic ingredients manufactured at the nanoscale are variations of additives already approved
for use in food, e.g. titanium dioxide, a food colorant, can be used as a UV protection barrier in food
packaging when used as a nanoparticle (Note: titanium dioxide loses its ability to act as a food colorant
in the nano form because it is transparent). New storage containers/utensils (food contact materials)
based on embedded inorganic nanoparticles have been designed for preservation of prepared foods.
The most common application is the use of nanoparticles of silver (Table 2.2) as an antimicrobial.
Applications for nanosilver include use in fridge panels, storage boxes, packaging lines and other
surfaces which come into contact with food during manufacture. Nanosilver particles have also been
added to non-food contact areas such as floor tiles to reduce the bacterial load in the surrounding
manufacturing environment. Food storage bins are being produced with silver nanoparticles
embedded in the plastic, killing bacteria from any food that was previously stored in the bins and
minimising health risks.
Inorganic nanoceramic, solid pellet nanoparticles, have been added to oil cooking systems (Table 2.2)
in restaurants in the USA to extend the life of chip oil while giving a crisper food.The technology is
based on the ability of the nanoceramic particles to act as a catalyst, limiting thermal polymerisation
process in the oil resulting in a crisper deep-fried food and longer shelf-life for the oil.
2.2.1.2  Organic nanoparticles
Organic nanoparticles (sometimes referred to as nanocapsules when used as vehicles for delivery of,
e.g. essential nutrients or pharmaceuticals) are likely to be used to enhance the nutrient value of food
systems through improvement or alteration of food functionality. Nanoparticles have been designed
to deliver vitamins or other nutrients in food and beverages without affecting the taste or appearance.
These nanoparticles encapsulate the nutrients and carry them via the gastrointestinal tract (GIT) into
the bloodstream, increasing their bioavailability.
F OO D S A F E T Y AU T H O R I T Y O F I R E L A N D
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Micelles are organic nanoparticulates that can be assembled by the thermodynamically driven process
known as self–assembly. Micelles made in this way have the ability to encapsulate non-polar molecules
such as lipids, flavours, antimicrobials, antioxidants and vitamins (Chen, 2006). Compounds that are
normally insoluble or only sparingly soluble in water can be made water soluble, extending their use
in foods and potentially changing their bioavailability once ingested. For example, one company has
developed a micelle-based technology (Table 2.2) which combines two active substances, coenzyme
Q10 (CoQ10) for fat reduction and alpha-lipoic acid for satiety into a single nanocarrier (micelles of
average 30nm diameter).The application is targeted at the weight management market.
Another example is a liquid droplet technology named ‘Nano-sized Self-assembled Liquid Structures
(NSLS)’, which encapsulates and releases particles in cells. The micellar particles are used to
encapsulate nutraceuticals (lycopene, beta-carotene, lutein, phytosterols, CoQ10, docosahexaenoic
acid/eicosapentaenoic acid (DHA/EPA) and other compounds) into 30nm diameter self-assembled
spheres. The micelles are essentially made from lipid molecules and have a unique hydrophobic
interior.The NSLS particles are reported to act as vehicles for compounds to be absorbed into the
bloodstream from the gut more readily, increasing their bioavailability.The technology has already been
adopted and marketed by an American company to deliver an oil-based product (Table 2.2), which it
claims can reduce cholesterol intake into the body by 14%, by competing for bile solubilisation.
Casein micelles (particles with diameters in the range 60 – 300nm) in fresh skim milk can be
reassembled from acid casein in the presence of calcium phosphate (Mounsey et al., 2005). Re-
micellisation of casein in this way confers different functionality on the protein while maintaining the
ability of the milk to form gels on the addition of the enzyme chymosin, commonly used in cheese
making.
Liposomes are another example of micelles and can be used to encapsulate both water and lipid
soluble compounds (Taylor et al., 2005).The dissolution of fat-soluble nutrients in water-based drinks
is one of the key applications of liposomes.Table 2.2 provides an example of one such encapsulating
vehicle that can be used to encapsulate nutraceuticals for oral delivery. Examples of current research
into the use of liposome technology in food is the encapsulation of enzymes, lactic acid bacteria
extracts and/or antimicrobials for accelerated cheese ripening. Liposomes can be produced to
differing sizes (10 – 500nm) and engineered to have different stability and/or surface charge under
different environmental conditions. Development work utilising this technology is already ongoing in
Ireland at Moorepark Food Research Centre, using liposomes as agents to accelerate cheese ripening.
Liposome technology can be used potentially to target specific sites within a food product for
enzymatic degradation.
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2.2.2 Nanofibrils/Nanotubes
Recent research has demonstrated that many globular food proteins, including the whey proteins
(alpha-lactalbumin, beta-lactoglobulin) and bovine serum albumin, can self-assemble into fibrils (“nano-
fibrils”) at high temperature and low pH. Nano-fibrils typically have a diameter of ~ 5nm and lengths
of up to 15µm. Under appropriate conditions, alpha-lactalbumin can be partially hydrolysed by
protease enzymes from Bacillus licheneiformis (Graveland-Bikker and de Kruif, 2006). When this
partially hydrolysed protein is exposed to calcium ions, the formation of linear nanotubes is triggered.
Alpha lactalbumin nanotubes have good thermal stability and can be subjected to dehydration
processes such as freeze-drying for prolonged storage.The transparent gel network formed by these
nanofibrils may have many uses in the agrifood sector as a thickening agent. At the time of publication
of this report, the nanotubes described here have been the subject of research, but are not currently
used in food.
Table 2.2  Applications of Nanotechnology in Food – Examples of Products
Currently on the Market (non-exhaustive list)
Product Example Nanomaterial or Application Area
Technology Used
MesoSilver
MesoGold
MesoCopper
MesoPlatinum
MesoPalladium
MesoIridium
MesoTitanium
MesoZinc 
Colloidal Silver
Cream
Colloidal Silver
Liquid
Nano Silver
dispersion
Synthetic Lycopene
OilFresh
Nanoparticles of silver
or gold
Copper
Platinum
Palladium
Iridium
Titanium
Zinc
Nanosilver
Nanoparticles of
lycopene
Zeolite 
Food supplements
Silver nanoparticles have been incorporated
into different products from bandages to
refrigerators for suppressing the spread of
bacteria and other microbes (Nanosilver,
2004)
Nutraceutical
OilFresh is a device to keep frying oil fresh.
OilFresh uses zeolite, a mineral, in the form
of beads with an average diameter of 20
nanometers across, coated with an
undisclosed material 
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Table 2.2  Continued
Product Example Nanomaterial or Application Area
Technology Used
Aerosil
Titanium dioxide
Silicon dioxide
Silver
MultiSal™
Fabuless™
Nutralease
Canola Active Oil
Nanocalcium 
and Magnesium
Nanoceuticals Slim
Shake Chocolate
Durethan
Imperm
NovaSOL
Encapsome™
Silica Nanoparticles 
Nanoparticles
Nanoparticles
Emulsion
Nanoparticles
Nanoparticles
Nanoclusters
Nanoclay
Nanocomposites 
of nylon
Miceller organic
nanocapsules
liposomes (Micellar)
Used to increase flowability of powdered
ingredients
Packaging materials containing nanoparticles
of titanium dioxide, silicon dioxide or silver,
which increase shelf-life of food by modifying
mechanical and heat resistance properties,
and developing antimicrobial and antifungal
surfaces
Delivery system for active ingredients 
(water and fat soluble)
A nanoemulsion that delays digestion until
lower regions of the small intestine,
stimulating satiety and reduce food intake
Enhances the solubilisation and bioavailability
of nutrients
Canola oil fortified with free phytosterols to
reduce cholesterol levels
Mineral supplement with increased
bioavailability
Slimming drink using nanoclusters to
enhance flavour without the need for added
sugar 
Transparent plastic film (called Durethan)
containing nanoparticles of clay to block
oxygen, carbon dioxide and moisture from
reaching the food
Nanocomposites embedded in plastic beer
bottles that give a six month shelf-life to
beer
Delivery system for hydrophobic substances
Nanoparticles capable of carrying both
water-soluble and oil- or fat-soluble
compounds within a single particle
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2.2.3 Nanoemulsions
Nanoemulsions are emulsions which are thermodynamically stable compared to conventional
emulsions under a range of different conditions.This is due to their small size (typically 50 to 500nm
compared to 1200nm) and monodispersivity. They can be diluted with water without changing the
droplet size distribution. The type of surfactant used to formulate a nanoemulsion is critical to the
stability of the final emulsion. Preparations of nano-emulsions can be used to encapsulate functional
food components at oil/water interfaces, or throughout the continuous phase of the system (Weiss
et al., 2006).
The applications of nanoemulsions include:
• delivery of active compounds in the body
• stabilisation of biologically active ingredients
• extended shelf-life due to increased stability
• increased viscosity at lower concentrations of oil phase.
Research has shown that stabilised mono-dispersed oil-in-water (O/W) or water-in-oil (W/O)
nanoemulsion systems can be used for controlled release of nutraceutical and other bioactive
components in food (Weiss et al., 2006).The technology has been combined with advanced processing
technologies to develop novel microencapsulated products that allow controlled release of food
bioactives in the gastrointestinal tract. These products may be either ready-to-drink or powdered
formulations fortified with functional ingredients from a wide range of sources. Process technologies
such as ultra high pressure homogenisation and micro-fluidisation have been used to create stable
mono-dispersed O/W or W/O nanoemulsions for the uses described.
The physical properties of nanoemulsions such as rheological and microstructural properties, phase-
separation behaviour and stability in food products is significantly different to those found in emulsions
manufactured using standard emulsification techniques. Incorporation of plant-derived nutraceuticals,
e.g. plant sterols, lycopene, limonenes, CoQ10, and protein-based bioactives into the oil phase (O/W
emulsions) or water phase (W/O emulsions) has already been successfully carried out using this
technology. One food company has produced a nanoemulsion (Table 2.2) which is not digested until
it passes to the lower regions of the small intestine where it stimulates satiety signals in the brain to
tell the body that food intake can be reduced. Because of their small particle size, nanoemulsions may
be used in the future in the development of low fat products due to the viscosity that is imparted at
low oil droplet concentrations.
Nanodispersions created by high pressure homogenisation and microfluidisation techniques have been
used to reduce the size of inorganic matter to a size which can be dispersed in aqueous solutions.The
technology can be used to create injectable versions of inorganic materials which can subsequently be
used in medical applications. Nanodispersions can remain in a stable suspension for a longer period
than larger particle based dispersions.
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2.2.4 Nanoclays
Nanoclays are used to provide an impermeable barrier to gases such as oxygen or carbon dioxide in
plastic bottles, cartons and packaging films. Many products containing nanoclays already exist in the
market place. For example, one chemical company produces a transparent plastic film which contains
nanoparticles of clay (Table 2.2).The nanoclay particles are dispersed throughout the plastic and are
able to block oxygen, carbon dioxide and moisture from reaching fresh meats or other foods. The
nanoclay also enables the plastic to be made thinner, lighter, stronger and more heat resistant. Similarly,
there is a US patent for nanoscale films that have been used as coatings. The coatings, made from
oxides of silicon or titanium, are anitmicrobial and can increase the life of many manufactured foods,
even after they are opened.
2.3 Research Trends in Nanotechnology and Food
2.3.1 Food contact materials including packaging
Applications of nanotechnology under research for use in packaging include: gas/UV barriers, foils
(mechanically and temperature reinforced), nanoclays, nanoparticles, nanopolymers, composites,
nanocavities and strings. These and similar technologies can provide packaging solutions with
functional properties of benefit to the consumer and/or the manufacturer. Promising developments
have also been made in the area of antimicrobial, breathable and multifunctional packaging. Packaging
which can release nanoscale antimicrobials, antioxidants and/or flavours to increase shelf-life and
sensory characteristics have already been developed (LaCoste et al., 2005).
Nanosensors are being developed for the purpose of detecting chemical contaminants, viruses or
pathogenic bacteria in food systems. Examples of nanosensors include particles, engineered at the
nano scale, to attach to pathogens or other contaminants which are then selectively identified by
fluorescence or magnetic devices. The advantage of these systems is the ability to identify a wide
spectrum of pathogenic organisms using just one sensor.
Currently, the research on nanosensors is focused in two areas, 1) the development of easy to use
rapid biosensors for the diagnostic detection of pathogens/contaminants in the foods (including
medical foods) and their surrounding environment and 2) the incorporation of nanosenors into food
packaging materials for tracking, safety and biosecurity purposes.An example of the latter is triggered
colour changes on the surface of a packaging materials to indicate food spoilage. Extreme condition
packaging, nanocoding of plastics and paper materials for identification purposes, monitoring tagging,
trade mark and fraud protection, will improve supply chain efficiency. Research on such technology is
likely to continue as the need to maintain food quality during transportation increases.
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2.3.2 Targeted delivery systems
One of the many benefits of nanotechnology is the ability to alter or enhance the release of molecules
from food matrices. Increased bioavailability through delivery of nutraceuticals, bioactive, and inorganic
materials promises to be one of the major applications of nanotechnology in the agrifood sector. In a
recent report by the RIKILT Institute of Food Safety, Wageningen UR and the National Institute of
Public Health and the Environment; Center for Substances and Integrated Risk Assessment in the
Netherlands (Bouuwmeester et al., 2007), the types of nanoparticles used as delivery systems have
been classified as shown in Figure 2.2
Figure 2.2  Classification of Nanoparticle Delivery Systems
(adapted from Bouuwmeester et al., 2007)
Encapsulated
Nanoparticles
Lipid-based
capsules
Polymer-based
capsules
Natural polymers
(e.g. albumin, collagen
alginates, gelatine, chitosan)
Synthetic polymers
(e.g. PLA, PLGA, PCL)
Nanoliposomes
Archaeosomes
Nanocochleates
Micelles
Nanospheres
Nanocapsules
Polymersomes
Micelles
F OO D S A F E T Y AU T H O R I T Y O F I R E L A N D
19
Research continues in this area and for example a system designed to release ingredients
consecutively has recently been developed. The manufacturers claim that the product (Table 2.2)
enhances the stability and bioavailability of nutrients and other ingredients by controlling their release
characteristics and prolonging their residence time in the oral cavity. The technology can be used to
prolong the sensation of flavour in the mouth.
Research is also underway to explore the use of nanoparticles in so-called interactive foods.This may
give consumers the ability to modify the characteristics of the food depending on their own nutritional
or organoleptic requirements, by controlling the release of ‘nanocapsules’ containing flavour/colour
modifiers and/or added nutritional elements, e.g. vitamins, which remain dormant in the food until
triggered by the consumer or retailer. Nanocapsules have been developed whose walls burst at
different microwave oven frequencies so the consumer can create new tastes or even colours.
2.4 Applications of Nanotechnology in Agriculture
As indicated in Chapter 1, the presence of nanoparticles in food as a result of accidental or deliberate
inclusion of nanomaterials in animal feed or as a result of environmental contamination, may be an
important route of human exposure.The current and potential applications of nanotechnology in the
food industry may equally be applied in the feed industry and some potential applications are briefly
outlined below.
2.4.1 Animal feed
In the short to medium term it is generally thought unlikely that nanotechnology will be used to a
significant extent in the development of animal feed ingredients, due to cost implications.What is more
likely is that nanotechnology products may enter animal feed through waste food or environmental
sources and possibly as additives following on from developments in the veterinary or human
medicines area. In these cases, the consequences of use of nanotechnology should already have been
comprehensively evaluated in the original use.
2.4.2 Other farm applications 
Farm applications of nanotechnology include more efficient and safe systems for the application of
pesticides, herbicides, and fertilisers, by better control of where and when they are released. An
example of this is provided by an environmentally friendly pesticide that incorporates nanomaterial as
a release mechanism for pest control agents and works only when inside the host. Nanomaterials in
the late stages of development include products that can detect and neutralise animal pathogens in
livestock before derived food products reach the consumer. Nanotechnology applications in
controlled environment agriculture include "smart" pesticide delivery, control of crops, animal health,
control of microbial and chemical contamination and complete plant health monitoring.
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Nanotechnology can also be used in agriculture to develop new tools for the treatment of diseases,
rapid disease detection, enhancing the ability of plants to absorb nutrients and other essential factors.
Smart sensors and smart delivery systems similar to the technology described above for food can be
useful to the agricultural industry to combat viruses and other crop pathogens. In the near future,
nanostructured catalysts will be available which will increase the efficiency of pesticides and
herbicides, allowing lower doses to be used. Nanotechnology may also protect the environment
indirectly through the use of alternative (renewable) energy supplies, and filters or catalysts to reduce
pollution and clean-up existing pollutants.
2.5 Nanotechnology and Water Purification
Nanotechnology can be used in water purification. A US company has developed 2nm diameter
aluminium oxide nanofibres as a water filtration aid, while a product containing lanthanum
nanoparticles can absorb phosphates from aqueous environments. Research at the Centre for
Biological and Environmental Nanotechnology (CBEN) has shown that nanoscale iron oxide particles
are extremely effective at binding and removing arsenic from groundwater.
2.6 Conclusion on Current Applications of Nanotechnology in Food
Many examples of nanoparticles with targeted release capabilities and functionalised packaging, with
potential uses in the agrifood sector, have been identified in the marketplace. Of these, probably the
most widespread actual or potential use is incorporation of nanoparticles into food packaging and
food contact surfaces. Nanosized particles of titanium dioxide, silver and clay are being used in
packaging and other food contact materials and the potential of these particles to migrate into foods
should be investigated.
The report identifies that currently there is no known direct use of complex organic nanoparticles
such as carbon nanotubes in foods. Furthermore, nanomaterials present in foods that are currently
available on the market, mostly through internet trading, are mainly in the form of nanoscale
encapsulated functional ingredients.
The potential benefits of using nanotechnology in food include the ability to monitor the quality of
food, and its surrounding environment, through the use of nanosensors.Antimicrobial biosensors and
controlled release technology may provide new approaches to food safety in the future. New textures
and flavours may be realised with “release on demand” functionality. It is the responsibility of the
manufacturer to ensure that products utilising nanotechnology in food or food contact surfaces
comply with applicable legal and regulatory requirements (see Chapter 5), while Governments and the
scientific community must provide reliable mechanisms for regulating the use of nanotechnology in
food.
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3.1 Introduction 
Nanoparticles encompass the full range of traditional material classes, including all forms of metals,
polymers, ceramics and biomaterials. The development of ever-smaller particles presents major
challenges, mainly because of difficulties in characterising the reliability, comparability and
reproducibility of materials on this scale. In response to these difficulties, a new and emerging
subdiscipline of metrology has begun to evolve. Nanometrology, as it has become known, is defined as
the ability to conduct measurements at sub-100nm dimensions and to fully characterise the nature of
these novel materials.
3.1.1 Nanometrology
Without reliable methods of measurement, it is impossible to determine human or animal exposure
via food or feed (see Chapter 4.4). Of specific importance therefore in relation to the food and feed
sector and to any potential regulatory framework is the determination of the physiochemical
properties of nanoparticles and their measurement in food. Such properties include:
• particle size 
• particle distribution
• surface area
• surface charge and topography
• composition and purity
• hydrophobicity and solubility
• chemical reactivity and bioactivity
• dispersion/aggregation state.
Particularly important among these properties are particle size and distribution, surface area and
aggregation state. Normally, nanoparticle samples contain a range of particles, both larger and smaller
than the mean or median value, which is often the figure actually quoted as the particle size. Figure
3.1 shows how the particle size may be distributed around the mean or median value in a Gaussian
distribution.As the particle size decreases, more molecules are present at the surface giving rise to a
larger surface to volume ratio or larger surface area for chemical interaction.
3. CHARACTERISATION OF NANOPARTICLES
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Figure 3.1  Typical Particle Size Distribution Curve for Silver (Ag) Nano-
powder Dispersed in Triton X100.The Silver Nano-powder is sold as having 
a Particle Size of <100nm.The Curve was Obtained using a Malvern
Instruments Zetasizer Nano
(courtesy of Dr G. Chambers, School of Physics, Dublin Institute of Technology)
Figure 3.2 shows a schematic of how the surface area changes as the particles become smaller.
Figure 3.2  Schematic of how the Surface Area Changes as the Particles
Become Smaller
(courtesy of Dr G. Chambers, School of Physics, Dublin Institute of Technology)
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The tendency of nanoparticles to aggregate, often as a result of the drying stage during the synthesis
process, is of particular importance to the characterisation of nanoparticles, as already indicated and
as shown in Figure 3.3. Aggregation is the process whereby small molecules or particles can come
together to form a secondary larger particle or cluster which is held together by one or more
molecular interactions such as Van der Waals forces or hydrogen bonds. This has considerable
implications for determination of the size and surface area of the nanoparticles, as well as for
determination of exposure.
Figure 3.3  Schematic of the Process of Aggregation of Primary Nanoparticles
to Form Larger Aggregated Particles 
(courtesy of Dr G. Chambers, School of Physics, Dublin Institute of Technology)
Primary Particle Partially Aggregated Aggregated
The perceived diameter increases with high degree of aggregation
Surface area decreases with increased aggregation
Well dispersed particles with
little interaction but small
imbalances in the charge
distribution or changes in the
local environment can increase
the degree of interaction
As the degree of interaction
increases the particles begin to
form small assembles via a
number of molecular
interactions.
Large particle assembles form
and dominate
Size: ‘nano’ - range Size: ‘nano - micro’ range Size can be ‘micro’ or ‘nano’
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Many characterisation techniques exist which can estimate or measure these properties. The
reliability, precision and accuracy of these techniques on the nanoscale are however often called into
question. In addition, environmental fluctuations, operator variation, and the lack of traceable
standards are further difficulties facing nanometrology and regulatory bodies.There is an urgent need
to establish calibration standards and protocols for the characterisation of nanoparticles. The ISO
TC229 Technical Committee on Nanotechnologies was established in 2005 to address these issues
and work is ongoing.
Most material characterisation techniques focus on the pristine particle (as-synthesised) in powder
form, following purification and/or drying. However, many applications of nanoparticles in food involve
complex environments, which can change the particle size, the aggregation behaviour, the dispersion
state, and several of the physical properties.Thus, a complete characterisation of the powder form may
not be relevant in terms of the nature of the particle as found in food.
Another aspect to be considered is the characterisation of the nanoparticles under a range of relevant
biological conditions, such as in complex food products, where they can interact with proteins, lipids,
sugars or other biomolecules. This may have consequences for the surface composition of the
nanoparticles and their aggregation behaviour, as the adsorbed proteins and biomolecules may have
different hydrophobicity, charge and charge distribution than the as-synthesised nanoparticles. The
adsorbed proteins and other biomolecules confer a “biological identity” (the biomolecule corona;
Lynch, 2006; Lynch 2007) to the nanoparticles, as it is these adsorbed molecules that are responsible
for the primary interaction with living systems.Additionally, the nanoparticles can alter the functioning
of the adsorbed biological molecules, e.g. enzyme activity, degradation and other properties, making
them more or less active than the unbound form (Palocci et al. 2007).A further set of characterisation
tests need to be performed on nanoparticles in biological matrices including food.3 The rest of this
chapter provides an overview of characterisation techniques for as-synthesised nanoparticles, i.e.
before interaction with biological molecules, and for nanoparticle-biomolecule complexes. It also
highlights the problems associated with the actual measurement of nanoparticles in biological matrices
such as food and body tissues.
3.2 Physical Characterisation Techniques and Issues
The techniques and instrumentation currently used for the physical and chemical characterisation of
nanoparticles, the majority of which could be adapted for use in food and feed, are summarised in
Appendix II, together with the properties of the nanomaterial that they are designed to measure. It
should be noted that the information provided in Appendix II does not represent a definitive list of
characterisation techniques and the instruments listed often require adaptation for nanoparticle
characterisation and specialist training. As a result, these instruments can often be expensive and
difficult for companies to justify economically.
3 Many of these issues are also relevant for nanomedicine, although here the point of first contact with biological material is
different, often being the blood stream. However, similar approaches to determining the biological identity of the particles can
be envisaged.
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Particular care must be taken when measuring aspects such as particle size and surface area as
nanoparticles are often highly aggregated and have very large particle size distributions, a fact that is
often overlooked or ignored when characterising nanoparticles.The sizes recorded are often only a
small fraction of the sample, rather than a true representation of the sample composition.A range of
techniques is commonly used to disperse nanoparticles, such as ultrasound sonication, dispersing
agents (common in food, e.g. emulsifiers), and milling. Even following these procedures, the dispersions
are often very polydisperse, and the surface may have changed, due to exposure of “fresh” surface due
to the breaking up of clusters.An important issue is to distinguish between the primary particle size,
which is typically on the nanoscale, and the cluster size due to aggregation, which may be either
nanoscale or micron scale (Figure 3.3).
3.3 Characterisation of Nanoparticles in Biological Matrices 
In considering the characterisation of nanoparticles in a biological environment, both the effect of this
environment on the nanoparticles and conversely, the effect of the nanoparticles on the environment
must be explored. Engineered nanoparticles, with their very large surface areas, adsorb biomolecules
to their surface immediately upon contact with natural substances (in the case of this report, food
and/or biological material in the mouth and digestive system) to form a biomolecule corona (Lynch,
2006; Lynch, 2007). These biomolecules include proteins, lipids and sugars, and it is these adsorbed
biomolecules that confer the biological identity of the nanoparticles, and determine how they interact
with living systems.
Many of the biophysical and biological techniques available to determine protein conformation and
activity can be applied to the characterisation of the nanoparticle-biomolecule complex (Lynch, 2006).
A list of techniques currently being used is presented in Appendix III, many of which could be applied
to/by the agrifood sector.Again, it should be noted that these tables are by no means a definitive list
of characterisation techniques and the instruments listed often require adaptation for nanoparticle
characterisation and specialist training.
The adsorption of biomolecules to the surface of engineered nanoparticles can affect their stability
and dispersion, and it is important to also characterise the dispersion properties of nanoparticles in
the relevant biological environment, e.g. in food. Many of the techniques listed in Appendix II can be
applied to the characterisation of the dispersion stability of the nanoparticle-biomolecule complex.
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An additional aspect of the adsorption of biomolecules to the surface of nanoparticles is the effect on
the conformation of proteins such as enzymes, and also on their function, stability, activity and
aggregation state, among other properties. There are a number of examples of enhanced enzyme
stability and function following adsorption to nanoparticles, for example, the lifetime of the enzymes
trypsin and peroxidase was shown to increase dramatically, from a few hours to weeks, by attaching
them to magnetic iron nanoparticles (Sharma, 2007). This ability to enhance protein stability by
interfacing them with nanomaterials may impact numerous biological processes such as digestion,
metabolism and nutrient uptake. These effects of nanoparticles need to be characterised and
measured, as discussed further in Chapter 4 (Section 4.2.2.3) of this report. Measurements of
enzymatic activity in the presence of nanoparticles should be studied as a priority, and many of the
techniques listed in Appendix III may be valuable for this purpose.
3.4 Measurement of Nanoparticles in Food and other Biological Matrices
The preceding paragraphs have shown that a wide range of physical and chemical techniques are
available to characterise nanoparticles, both in the as-synthesised form and as nanoparticle-
biomolecule complexes such as would occur in food matrices and upon ingestion. While these
techniques may be applied to carry out measurements of nanoparticles in the pure form, the
measurement and quantitation of nanoparticles in food, biological tissues and other biological matrices
presents considerable challenges, since suitable equipment and measurement strategies are not yet
available (SCENHIR, 2006, 2007).
Many food products also contain considerable amounts of naturally occurring nanoparticles, such as
proteins, silica or traces of titanium dioxide, which makes detection of added nanoparticles difficult,
as it rules out techniques such as elemental mapping where there are already significant background
levels. Techniques such as elemental mapping can only be applied to nanoparticles such as gold and
silver, which are not naturally present in foods or food packaging materials.
Measurement of particle mass of nanoparticles in the pristine form (as synthesised), is relatively
straightforward, while measurement of the surface area of a given mass of nanoparticles is more
difficult, as many of the current techniques do not distinguish fully between porosity and surface area,
e.g. nitrogen adsorption.An additional complication is, as already discussed, the very ready aggregation
of nanoparticles that occurs in biological media, resulting in larger particles, or even a gradual increase
with size as a function of time. Such aggregation makes it almost impossible to measure either particle
number or surface area in biological matrices. These technical difficulties in the measurement of
nanoparticles make it correspondingly difficult to measure the actual exposure in in vitro and in vivo
toxicological studies or in exposed humans for risk assessment purposes, as discussed further in
Chapter 4.
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3.5 Conclusions on the Problems Associated with Measurement and 
Characterisation of Nanoparticles
The characterisation of nanoparticles requires considerable care and there are many difficulties and
uncertainties, in particular with respect to particle aggregation, size, purity, and batch variations.The
characterisation is further complicated by the incorporation of nanoparticles into biological matrices.
This alters their properties and requires further characterisation beyond that of the pristine
nanoparticle. The adsorption of biomolecules to nanoparticle surfaces may have particular
consequences for nanoparticles in food. For example, absorbed enzymes may have enhanced or
reduced activity, resulting in altered efficiency of digestion and altered nutritional value of foods.
It is particularly important to distinguish between nanoparticles and nanoparticulate aggregates.
Nanoparticles that have been dried during the synthesis process are typically irreversibly aggregated,
and as such have dimensions on the micron scale. If the nanoparticles remain in suspension, upon
contact with biological fluids, their surface properties may be altered by adsorption of proteins and
other biomolecules, resulting in altered stability and aggregation. Nanoparticles need to be
characterised under the conditions in which they will be utilised.
While many methods exist to characterise as-synthesised nanoparticles, such as electron microscopy
and scattering methods, new methodologies are required urgently to characterise nanoparticles in situ
in food matrices and food contact materials. At present, it is not possible to distinguish between
background levels of nanoparticles and purposely added nanoparticles such as silica dioxide and
titanium dioxide. Nevertheless, the nanometrology area is rapidly developing, with a concerted effort
to develop standards and standard procedures for the characterisation of nanoparticles and
nanoparticle-based systems.
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4.1 Introduction
Typically, risk assessment consists of four components: hazard identification, hazard characterisation,
exposure assessment, and risk characterisation, as illustrated in Figure 4.1.All four of these stages are
essential to the process of risk assessment.A substance may be extremely hazardous, but have a small
exposure potential, and the risk may be small,whereas something that is of limited hazard but to which
exposure is high and/or over long periods may present a much greater risk. It is essential to
characterise both the nature of the hazard and the exposure.
Risks must be considered in the early stages of any new technology.The assessment of the potential
risks of nanotechnology to consumers using the conventional risk assessment model has already been
the subject of a number of expert reports, e.g. SCENIHR, 2006, 2007; SCCP, 2007; FDA, 2007; COT,
2005; BfR, 2007; Bouwmeester et al., 2007.The FSAI’s Scientific Committee has applied the framework
to the use of nanotechnology in the agrifood sector, as outlined in the following sections of this
chapter.The report focuses on risk assessment of nanoparticles following exposure via the oral route
of exposure since this is the relevant route in assessing the safety of nanotechnology in food. In
addition, the report has attempted to identify the limitations in traditional approaches to exposure
assessment and hazard characterisation of chemical risks when they are applied to nanotechnology,
and to suggest areas where research may be needed.
Figure 4.1  The Risk Assessment Model
4. RISK ASSESSMENT OF NANOPARTICLES 
IN THE FOOD CHAIN
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As discussed in Chapter 2 there are many applications of nanotechnology in the food and animal feed
industry that are either already in use or are subject to active research programmes. Prior to the
incorporation of nanomaterials into new and existing food and feed applications, their potential
toxicity and biological compatibility need to be investigated and the potential hazards should be
identified before their use becomes widespread (Smart et al., 2006). With an increasing number of
consumer and industrial products containing engineered nanoparticles, the risk of human exposure
increases and these materials may become a threat to human health and the environment
(Oberdörster et al., 2005).
4.2 Hazard Identification
As indicated in Chapter 2, the potential applications of nanotechnology in the agrifood sector range
from modifications of the natural (organic) protein, carbohydrate and fat molecules that form part of
the normal diet, to achieve added or altered functionality, to the use of inorganic nanoparticulate
materials in food packaging and food ingredients including food additives.The molecular nature of a
nanoparticle, e.g. inorganic or organic, and whether the molecule is naturally found in the body or not)
are key determinants of the potential hazards of the material, in addition to its physicochemical
characteristics such as shape, solubility, charge and chemical functionality. Properties such as particle
size and size distribution, agglomeration state, mass, chemical composition, surface properties, crystal
structure, surface area, surface charge and porosity may all be important for understanding the toxic
effects of nanomaterials (Maynard et al., 2006).As will be illustrated in the following paragraphs, these
characteristics influence how readily nanoparticles will be absorbed from the gastrointestinal tract
(GIT) and how rapidly they will be cleared from the body, in addition to influencing their toxicity.
In considering the hazard profile of a particular material in nano form, it can normally be assumed that
it will have similar hazards to the same material in a micro or macro form. If the corresponding micro
or macro material has an innocuous toxicological profile due to biological inertness and
biodegradability, the nanomaterial may similarly be predicted to be of low hazard. For example, it can
be argued that organic nanoparticles derived from substances occurring naturally in the body, such as
proteins and carbohydrates, are likely to be of low hazard, although the increased bioavailability of the
nano forms may have significant consequences in the body.The potential for increased allergenicity of
these macromolecules via alterations in protein or carbohydrate structure may also be of concern.
Essential nutrients may be rendered more bioavailable through the use of nanotechnology, with
consequent implications for Safe Upper Levels (SULs) and Recommended Daily Allowances (RDAs),
as discussed later in this report.
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On the other hand, inherently toxic materials such as particulate metal compounds (inorganic) 
can be anticipated to show similar or greater toxicity if produced in a nano form from which they can
solubilise (see section 4.2.1 on bioavailability and toxicokinetics). A body of evidence built up 
in in silico and/or in vitro models supports this premise and additionally indicates that many
nanoparticles show greater reactivity in such models (Meng et al., 2007; Papageorgiou et al., 2007; Singh
et al., 2007). In contrast, some studies have suggested that the nanoform may be less toxic than the
macroform. It has been reported, for example that selenium nanoparticles are less toxic to rats than
selenite or high-selenium proteins (Jia, 2005).
The same physical and chemical properties that make nanomaterials potentially useful for commercial
applications may be associated with potentially harmful effects on cells and tissues. Their increased
reactivity and their potential for unrestricted mobility make them appealing for delivery of boactive
molecules into poorly accessible compartments of the body such as the brain. There is however,
limited information available on the uptake, distribution and toxicity of nanoparticles (see Section 4.2.1
below), and it is recognised that nanoparticles can be toxic even if the bulk material is not due to
differences in bioavailability and reactivity (Owen, 2005).
The chemical reactivity of the surface area, including surface components, e.g. transition metals,
coatings, and the inherent toxicity of the chemical in question are particularly important. Properties
such as physical dimensions, surface charge and other factors determine whether a particle is able to
penetrate an organ or cell and if removal by phagocytes is possible. Nanoparticles on the same scale
as cellular components and larger proteins might evade the natural defences of the body. Together
with the solubility, this influences the retention time of particles.The longer a particle stays in contact
with cellular membranes, the greater the probability of a toxic reaction and damage (Royal Society,
2004; Smart et al., 2006).
In addition, as previously indicated in Chapter 3, immediately upon contact with natural substances,
e.g. biopolymers found in food, biological membranes such as those of the mouth and digestive system,
engineered nanoparticles will adsorb biomolecules including proteins, lipids and sugars to their
surface. It is these adsorbed biomolecules, referred to as the biomolecule corona (Lynch, 2006, 2007),
that confer the biological identity and potentially the toxicity of the nanoparticles, and determine how
they interact with living systems.The large surface area of nanoparticles allows a greater contact area
with cellular membranes as well as greater capacity for absorption and transport of toxic substances.
Assessment of the effects of nanoparticles on food components and their bioavailability therefore
needs to be considered. For example, binding of nutrients to nanoparticles could result in their
digestion being altered, or result in altered absorption into the body. At present, methods to
determine altered digestion in vitro could be applied, using approaches such as limited proteolysis, but
such research has yet to be reported in the scientific literature, and as such represents a knowledge
gap.
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4.2.1 The toxicokinetics of nanoparticles 
(Absorption/bioavailability, distribution, metabolism, excretion (ADME))
Section 4.2 on hazard identification has suggested that substances/materials in nanoparticulate form
may be as hazardous or more hazardous than the same substance/material in the micro or macro
form.The likelihood that this hazard will actually present a risk to human health and the environment
depends on (a) the potential for toxicity following exposure (see section 4.2.2) and (b) the potential
for exposure (see section 4.4). The toxicity of any substance is influenced by a number of factors
including its bioavailability, namely the amount of the substance absorbed by the body from the site of
first exposure, e.g. the lungs or the GIT. A key characteristic of nanoparticles, particularly insoluble
nanoparticulates, is that on a mass basis their bioavailability can be predicted to be higher than that of
the equivalent micro or macro form.This has been confirmed in a number of experimental studies
(Hecq et al., 2006; Kotyla et al., 2008).
To date, studies on exposure, absorption and bioavailability have focused on the inhalation and dermal
routes, and little is known about the toxicokinetic processes following oral exposure, particularly in
relation to ingestion of nanomaterials contained in food. Interest in the inhalation route of exposure
in part reflects the importance of this route in the occupational situation and the concern that
workers in the nanotechnology industries could be exposed to new hazards presenting long-term
risks to their health, leading to the suggestion that certain nanoparticulate materials could be as toxic
as asbestos (Poland et al., 2008). Studies have shown the importance of particle solubility, charge and
size in determining deposition and fate in the lung, as would be predicted (Kreyling et al., 2002, 2004;
Frampton et al., 2004, Oberdörster et al., 2005). Similar principles apply when considering exposure to
and uptake of nanomaterials by the dermal route. Nanotechnology may have particularly important
applications in the development of innovative cosmetics (SCCP, 2007) and uptake of nanomaterials via
the dermal route has been demonstrated (Ryman–Rasmussen, 2006; Xin-Rui et al., 2006, as reported
in SCCP, 2007).
The primary route of relevance to food safety is however the oral route, and discussion of the
toxicokinetics of nanoparticles in this report has therefore been largely limited to the oral route.
4.2.1.1 Absorption/uptake of nanoparticles from the gastrointestinal tract 
Little information is currently available concerning the uptake of nanoparticles from the intestinal tract
following oral exposure. Uptake occurs variously by passive diffusion across the mucosal cells, via
active transport mechanisms and intercellularly (O'Hagan, 1996). Nanoparticles can enter the GIT in
many ways, such as ingestion directly from food and water and from administration of therapeutic
nano-drugs. Inhaled nanoparticles can also be swallowed and enter the GIT following clearance from
the respiratory tract (Hoet et al., 2004). Particle uptake in the GIT depends on diffusion and
accessibility through mucus and contact with the cells of the GIT. The smaller the particle diameter,
the faster is the diffusion through GIT mucus to reach the cells of the intestinal lining, followed by
uptake through the GIT barrier to reach the blood.
Organic nanoparticles such as casein micelles are likely to behave similarly to their micro or macro
equivalents and can be predicted to be readily absorbed and highly bioavailable. One aspect that is to
date largely unresearched is whether higher molecular weight organic nanoparticles such as proteins,
fats or carbohydrates will be broken down to lower molecular weight entities in the GIT in the same
way as the native molecules, or whether they will be taken up intact. Insulin encapsulated in vitamin
B12-dextran nanoparticles has recently been shown to be taken up from the GIT without degradation
(Chalasani et al., 2007).
The intestinal uptake of inorganic, insoluble nanoparticles such as titanium dioxide and gold particles,
and also of insoluble polymers such as latex, has been described in several publications, e.g. Jani et al.,
1990; Florence, 2001; Hillyer and Albrecht, 2001; Hoet, 2004). On a mass basis, it can be predicted that
these insoluble nanoparticles will be more readily taken up across the intestinal barrier and hence be
more immediately bioavailable than their micro or macro equivalents. Uptake is largely determined by
particle solubility, charge and size (Jani et al., 1989, 1990, O'Hagan, 1996). Table 4.1 provides an
overview of a number of experimental studies that have demonstrated uptake of nanoparticles across
the GIT following oral administration.
Table 4.1  Uptake of Nanoparticles across the GIT following Oral Administration
Particle Type Particle Size Translocation/Distribution Reference
Titanium
dioxide
Gold
Polystyrene
C60 fullerenes
Nano Copper
Cationic
PAMAM 
dendrimers 
25 and
80nm
4, 10, 28,
and 58nm
given in
drinking
water
50nm
100nm
300nm
1000nm
3000nm
Not
available
23.5nm
Not
available
Böckmann et
al. 2000; Jani
et al. 1994
Hillyer and
Albrecht,
2001
Jani et al.
1990
Yamago et al.
1995
Chen et al.,
2007
Roberts et
al. 1996
uptake into the blood and movement 
to the liver
4nm particles were widely distributed to 
lung, heart, kidney, spleen and liver, with 
lower levels being found in blood and brain.
Levels of 10nm particles in these organs 
were generally 2-4 times lower than for 
the 4nm particles, while levels for the 
28nm particles were approximately 10 
times lower.There was little evidence 
of uptake of the 58nm particles
34% of 50nm particles and 26% of 100nm
particles were absorbed. Of the absorbed
particles 7% of the 50 nm and 4% of the 
100nm were found in liver, spleen, blood,
bone marrow. Particles greater than 
300nm did not enter the bloodstream
73-80% of oral dose found in liver
severe toxicological effects in liver,
kidney, and blood
three animals died after single oral
administration. Liver toxicity was observed after
multiple dosing (once a week for 10 weeks)
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Uptake of inert particles has been shown to occur trans-cellularly through the intestinal lining and
to a lesser extent between epithelial cells (Aprahamian et al., 1987; Hussain and Florence, 1997,
Hussain et al., 1998, 2001; Florence and Hussain, 2001).
4.2.1.2 Distribution, metabolism and excretion of nanoparticles following absorption from the
gastrointestinal tract 
To date, relatively few studies have investigated the uptake and disposition of nanomaterials by the
GIT, and most have shown that, dependent on size, nanoparticles either pass through the GIT without
uptake into the body and are eliminated rapidly (Oberdörster et al., 2005), or they cross the lining of
the GIT and enter the blood stream, from whence they relocate to other organs. Following uptake by
the GIT, gold nanoparticles of less than 50nm translocated to the blood stream and distributed all over
the body (Table 4.1; Jani et al., 1990). A recent study demonstrated that tissue distribution of gold
nanoparticles after intravenous (IV) administration was size dependent with the smallest (10nm)
particles showing widespread organ distribution (De Jong et al., 2008). As with absorption, the
distribution, breakdown and excretion of nanoparticles in the body will be dependent on
physicochemical characteristics such as solubility, charge and size.
Distribution/translocation of nanoparticles to body organs is expected to mirror that of their micro
or macro equivalents, with small water-soluble or fat soluble organic nanomaterials such as lipid
nanoparticles being widely distributed throughout the body. It can be anticipated that distribution and
breakdown of such nanoparticles into constituent molecules occurs rapidly and efficiently, with
subsequent clearance from the body. It is emphasised, however, that this supposition is based on
theoretical considerations and there is no experimental evidence to support this.A further area about
which little is known is the possibility of changes in physicochemical properties in moving to the
nanoscale, e.g. fat-soluble vitamins may become water-soluble either directly or by use of nano-
carriers, and vice versa.This, in turn, will lead to changes in the toxicokinetic profile of the vitamin or
other biologically-active molecule and potential cascade effects on cellular homeostasis.
These anticipated changes in bioavailability of biologically-active endogenous molecules, such as
vitamins and hormones, on moving to the nanoscale needs further investigation before the technology
is more widely introduced, as they have profound implications for concepts such as Safe Upper Level
(SUL) and Recommended Daily Allowance (RDA) for vitamins. The same applies to the Acceptable
Daily Intake (ADI) established for food additives and other food chemicals potentially found in food.
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Insoluble nanoparticles (primarily inorganic, but also including man-made polymeric materials such as
polystyrene and carbon-based nanoparticles such as fullerenes) can be predicted to have a more
restricted distribution. Following uptake from the GIT, nanoparticles can translocate via the lymph
system to the liver and spleen, as demonstrated for polystyrene nanoparticles of 100nm or less (Jani
et al., 1989, 1990). Smaller particles that are capable of being taken up by the villus epithelium (Jani,
1990, Hillery, 1994) may directly enter the bloodstream, and are then predominantly scavenged by the
liver and the spleen. A particular concern regarding the safety of nanoparticles is the possibility for
these small particles to evade the protective blood-brain barrier and enter the brain.This property
may be desirable and exploited in the case of delivery of therapeutic agents, but has significant health
implications in the case of insoluble nanoparticles such as polymers and metal compounds that would
not normally reach the brain in their micro or macro forms, as this may result in damage to this
vulnerable organ.
Insoluble but ultimately biodegradable polymeric nanoparticles such as chitosan, poly(lactide-co-
glycolide) (PLGA), gelatine and modified dextran are being explored as oral drug delivery systems and
potentially as delivery systems for food components.These materials will ultimately be broken down
into their constituent molecules and excreted, at a rate dependent on their physicochemical
characteristics. Relative persistence in the body, together with their potential for ultimate total
breakdown can be exploited to provide a slow release system, both for delivery of drugs and food
components.
In contrast, inorganic materials and non-biodegradable polymers such as titanium dioxide and
polystyrene will not be broken down. If these nanoparticles are bioavailable to any extent/are taken
up from the gastrointestinal system, there is the potential for accumulation in the reticuloendothelial
system of the liver and spleen and also, theoretically, translocation to other organs including the brain.
In addition, the potential for local toxicity in the GIT of non-bioavailable, non-biodegradable, orally-
ingested material must be considered.
4.2.2 Toxicity of nanoparticles 
4.2.2.1 Toxicity of nanoparticles in vitro and underlying mechanisms 
Much of the current knowledge concerning the potential toxicity of nanoparticles (nanotoxicology)
has been obtained from in vitro or in silico test systems and is suggestive of a common mechanism
underlying the toxicity of many nanoparticles.This may involve, in a three step process, generation of
reactive oxygen species (ROS) (Xia et al., 2006; Duffin, 2007), stimulation of an inflammatory response
and cytotoxicity (Brown et al., 2007; Foucaud et al., 2007). Xia et al., 2006 have suggested that
measurement of ROS generation and oxidative stress provides a valid test system to compare
nanoparticle toxicity. Although not all materials have electronic configurations or surface properties
to allow spontaneous ROS generation, particle interactions with cellular components are capable of
generating oxidative stress.
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These changes are typically also produced by micro particles and fibres, both inorganic and organic
(Bernstein et al., 2005; Cardinali et al., 2006; Donaldson and Tran, 2002). Historically, much of the
nanotoxicology data have originated from data on air pollution particles (Frampton et al., 2004,
Oberdörster et al., 2005). These particles have been studied both in vitro and in vivo, and have been
clearly demonstrated to be involved in human disease processes (Augur et al., 2006; Bai et al., 2006,
Donaldson et al., 2004; Pope et al., 2002).
In vitro studies with different types of nanoparticles (metal/metal oxide, titanium dioxide, carbon
nanotubes and silica) on various cell lines (lung and liver) have demonstrated oxidative stress-related
inflammatory reactions.The authors have postulated that this response is driven by the specific surface
area of the nanoparticle and/or its chemical composition (Ghio, 1999; Hussain et al., 2005; Lin et al.,
2006; Pulskamp et al., 2007; Singh et al., 2007).Typically, the biological activity of particles increases as
the particle size decreases. Smaller particles occupy less volume resulting in a large number of
particles with a greater surface area per unit mass and increased potential for biological interaction
(Oberdörster et al., 2005).
More recently, much of the fundamental data on model nanoparticles have been generated on non-
biodegradable, non- deformable spheres such as polystyrene and latex or, more recently, the carbon-
based nanomaterials such as fullerenes and carbon nanotubes (CNT). It should be noted however that
these materials do not reflect the typical profile for nanoparticles to be used in food industry
applications, as outlined in Chapter 2.
4.2.2.2 Toxicity of nanoparticles in vivo
Much of the data on particle toxicity have originated from studies on air pollution (Peters and Pope,
2002; Frampton et al., 2004; Oberdörster et al., 2005).The particles generated in air pollution episodes,
which include both micro- and nanoparticles, have been demonstrated to produce disease in animal
models exposed via inhalation, in addition to human disease. In relation to more recently characterised
nanoparticles, CNT have probably been the most extensively investigated and much of the in vivo
toxicity data in the literature relates to them (Huczko et al., 2001; Lam et al., 2004;Warheit et al., 2004;
Shvedova et al., 2005). Nearly all in vivo studies on CNT have found histological evidence of
inflammation and granuloma formation in rodent lungs. It should be noted however, that in the
majority of these in vivo experiments, intratracheal administration of a single dose was directly
introduced to the trachea or pharynx of anaesthetised animals resulting in a less realistic exposure
scenario than natural inhalation. In addition it is well recognised that toxicity of CNT is hampered by
their tendency to aggregate, and the observed results might be related to overload conditions.
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Inhalation of ultrafine particles has been linked to thrombotic (blood clotting) effects. Radomski et al.
have demonstrated that mixed carbon nanoparticles and nanotubes (both MWCNT and SWCNT),
were able to induce platelet aggregation in vitro and, in addition to accelerate the rate of vascular
thrombosis in the rat carotid artery (Radomski et al., 2005). Carbon nanotubes have also been shown
to activate the human complement system via both classical and alternative pathways (Salvador-
Morales et al., 2006). Recently, however, PLGA nanoparticles conjugated with alendronate were shown
to have an acceptable degree of haemocompatibility following IV administration, suggesting that this
material may hold promise as an IV drug delivery tool (Cenni et al., 2008).
There are few in vivo studies involving routes of administration other than inhalation, and those that
have been reported mainly involve the dermal and IV routes of administration, reflecting the potential
promise of nanotechnology in cosmetic and drug delivery applications. The studies that do exist in
relation to uptake of nanoparticles via the digestive tract are generally on polymer-based soft
(biodegradable) micro- and nanoparticles designed for therapeutic applications such as drug delivery.
However, the same general principles that influence the potential toxicity of such ploymers, such as
particle size, particle shape, and particle surface (including the biomolecules adsorbed to the surface)
will also apply to inorganic and engineered nanoparticles.
Experimental studies involving oral exposure to nanoparticles have been conducted using copper
nanoparticles (Chen et al., 2006b; Chen et al., 2007) gold nanoparticles (Hillyer, 2001), PMMA
nanoparticles (Araujo, 1999) and chitosan nanoparticles (Loretz, 2007). The distribution of copper
nanoparticles in different organs of mice after a single dose oral exposure suggested that the main
target organs are kidney, blood and, in particular, liver (Chen et al., 2007).A comparison of the toxicity
of copper nanoparticles (23.5nm), micro-copper particles (17µm) and cupric ions (CuCl2·2H2O) to
mice exposed via oral gavage resulted in the classification of nano and ionic copper particles as class
3 (moderately toxic), and micro-copper as class 5 (practically non-toxic) on the Hodge and Sterner
Scale (Chen et al. 2006b). Copper nanoparticles induced severe toxicological effects and organ toxicity
in kidney, liver and spleen of experimental mice, but micro-copper particles did not, on a mass basis.
Reflecting the results of the in vitro studies, an inflammatory response to nanoparticles has frequently
been observed in vivo, related to the tendency of nanoparticles to induce ROS (Xia et al., 2006; Duffin,
2007) which is a key step in the induction of an inflammatory response. Experimental studies have
shown that the extent of inflammation in vivo is a function of the surface area dose instilled (not of
the mass dose instilled). Low-toxicity nanoparticles including inert polymeric materials such as
polystyrene nevertheless have a high surface area, and are relatively inflammogenic.These approaches
present the possibility of measuring the potential toxicity of nanoparticles based on the inflammatory
response of a given instilled surface area dose (Duffin, 2007).
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On the other hand, there are also cases reported of nanoparticles having anti-inflammatory
properties, such as certain cerium oxide nanoparticles (Tsai, 2007) and silver nanoparticles (Bhol and
Schechter, 2007). Nanocrystalline silver (NPI 32101) has been demonstrated to have antimicrobial and
anti-inflammatory properties and was found to reduce colonic inflammation following oral
administration in a rat model of ulcerative colitis, suggesting that nanosilver may have therapeutic
potential for treatment of this condition (Bhol and Schechter, 2007). It would appear that no generic
assumptions can be made regarding the toxicity of nanoparticles.
In considering the effects reported in the paragraphs above, indicating an enhanced toxic potential of
nanoparticles compared with macroforms of the same material, it should be recognised that these
data on nanoparticles identified in air pollution and derived from experimental studies on CNT
nanoparticles and those derived from metals, metal oxides and polymeric materials, while providing
valuable information on the potential toxicity of nanoparticles and mechanisms of toxicity, are less
relevant for identifying the potential hazards of organic nanoparticles such as proteins and lipids.The
latter are the primary applications of nanotechnology in food, as outlined in Chapter 2, and many/the
majority are derived from endogenous compounds occurring naturally in the body.
4.2.2.3 Novel potential toxicities of nanoparticles and issues specific to food and digestion
One of the major uses of nanoparticles in food is likely to be nanoscale protein assemblies formed
from re-engineered proteins, e.g. use of protein fibrils as texture modifiers or structural elements in
foods (Graveland-Bikker and de Kruif, 2006). As already discussed, the common perception is that
these are natural as opposed to engineered nanoparticles and not likely to be a source of toxicity.
There is however emerging evidence that anomalous protein assemblies can themselves be a source
of toxicity, and/or could induce other proteins to aggregate/fibrillate. Preliminary evidence indicates a
potential role for nanoscale surfaces in modulating the rate of protein fibrillation (Linse, 2007), which
in turn indicates a need for further research into the effects of nanoparticulates on protein assembly
and aggregation. It should be emphasised that these studies were in solution, under non-physiological
pH conditions, and with single protein solutions, which do not represent the physiological conditions,
but rather are the standard conditions to study the mechanisms of protein fibrillation.The fact that
the large surface area presented by nanoparticles can modulate the fate of fibrillation of proteins
offers both huge potential for the modulation of food properties and textures, but may also raise
questions as to whether nanoparticles in food could inadvertently induce protein fibrillation in the
food (altering its properties) or following adsorption in the body. This is a question that requires
further research.
Interaction of nanoparticles with components of food is another aspect that may need consideration
and about which little is currently known. It is well recognised that the toxicity of many chemicals in
the diet is markedly influenced by the food matrix, and that the toxicity profile predicted from in vitro
tests or certain in vivo studies in animals will not necessarily be manifest when the same chemical is
administered in the diet.The same is likely to be true of nanoparticles in the diet.
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Additionally, possible change in the nanoparticles following passage through the digestive system,
absorption, distribution and clearance from the body must be taken into consideration. Depending on
the nature of the biomolecule corona (described in Section 4.2 as the proteins, lipids and other
biomolecules which adsorb to nanoparticle surfaces immediately upon contact, thereby coating the
nanoparticles and conferring a “biological identity” to the nanoparticles) and potential for enzymatic
digestion, the behaviour of the nanoparticles may alter, and there is the potential for novel toxicities
not anticipated from the properties of the non-coated nanoparticles or the adsorbed biological
material. Much can be learned about the potential biological impacts of nanoparticles from the nature
of their biomolecule corona, and a useful topic for further research would be the recovery of
nanoparticles from the digestive system and characterisation of their corona using the techniques
summarised in Appendices II and III.
Finally, an issue to be considered in relation to nanoparticles in food is the potential role of
nanoparticles in inflammatory digestive diseases. For example, Inflammatory Bowel Disease (IBD) is a
chronic disorder characterised by recurrent and serious inflammation of the GIT (Zhong, 2008).There
have already been reports that microparticulates may play a role in Crohn’s disease (Lomer, 2002),
making a potential role for nanoparticles likely. A recent study has shown evidence of micro- and
nanoparticulates (in the form of inorganic, non-biodegradable pollutants, i.e. micro- and nano-debris)
in 18 samples of colon tissues affected by cancer and Crohn's disease (Gatti, 2007). Vulnerable
members of the population may include those with pre-existing digestive disorders, which may
potentially be impacted by the presence of nanoparticles, although on the other hand nanoparticles
offer many potential routes to therapies for these same diseases.
4.3 Hazard Characterisation 
The hazard characterisation step in risk assessment involves assessment of the toxicity of a particular
agent, e.g. a nanoparticle, the nature of that toxicity and the information available on the dose:response
relationship. Section 4.2 has provided an overview of the potential toxicities of nanoparticles,
particularly of insoluble inorganic and non-biodegradable materials (which are however unlikely to be
of major relevance in terms of applications of nanotechnology in food). Determination of the
dose:response relationship for the potential toxicities induced by nanoparticles is however extremely
difficult at the current time, due to the problems associated with measurement of dose in either in
vitro or in vivo toxicological studies, as discussed in the following Section 4.4 on exposure.The hazard
characterisation step is therefore hampered by gaps in the knowledge base, and modification of the
traditional risk assessment model in this area may be necessary in carrying out risk assessments of
nanoparticles, particularly in in vivo studies.
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4.4 Exposure to Nanoparticles
4.4.1 Routes of exposure 
As illustrated in Figure 4.2, there are various exposure routes for engineered and natural
nanoparticles.The majority of the available data on exposure to nanoparticles relate to the inhalation
route (via occupational and environmental exposure and potentially via new drug delivery systems
involving nanotechnology) and the dermal route (occupationally, via cosmetics and skin care products).
Nanoparticles may additionally be injected into the body for therapeutic purposes.While the primary
focus of this report is on the oral route of exposure, via food, it is useful to summarise the state of
knowledge regarding inhalation and dermal exposure.
Figure 4.2  Possible Exposure Routes for Nanoparticles 
SKIN ENVIRONMENTAL
WATER AIR
FOOD
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In relation to inhalation exposure, nanoparticles may be inhaled in significant amounts via
environmental exposure (due to air pollution) or in workplaces during manufacture of nanomaterials.
Nanoparticles have been demonstrated to enter the body more readily than larger particles (Borm
and Kreyling, 2004). Particles of 100nm or less have the potential to be inhaled following their
suspension in air as a result of air pollution and during manufacture, distribution, use and disposal of
nanomaterials.Those in the range of 20-100nm will lodge primarily in the upper airways, while those
in the range of 10-20nm and below will enter the lung alveoli from where they may be translocated
to other sites in the body, depending on their physical and chemical characteristics including solubility.
They may interact with alveolar macrophages, resulting in clearance (removal by the immune system),
or they can enter the lung interstitum where they may make contact with fibroblasts, endothelial cells
and/or cells of the immune system (Oberdörster et al., 2005).A build up in the lung may occur, due to
macrophage toxicity and decreased clearance, with resultant inflammatory change and other lung
toxicity (Oberdörster et al., 2005).
The skin represents a major route of exposure to nanoparticles contained in cosmetics and skin care
products. Occupational and environmental exposure to nanoparticles may also occur, particularly
during manufacture of nanoproducts.The EU Scientific Committee on Consumer Products (SCCP), in
their scientific opinion (SCCP, 2007), state that “there is evidence of some skin penetration into viable
tissues (mainly into the stratum spinosum in the epidermal layer, but eventually also into the dermis) for very
small particles (less than 10nm), such as functionalised fullerenes and quantum dots, but that when using
accepted skin penetration protocols (intact skin), there is no conclusive evidence for skin penetration into viable
tissue for particles of about 20nm and larger primary particle size ….. Nanoparticles of 20nm and above
penetrate deeply into hair follicles, but no penetration into viable tissue has yet been observed.” Zinc and
titanium oxide particles, as used in cosmetics have already been shown to penetrate the stratum
corneum of rabbit skin (Lansdown and Taylor, 1997) and highest absorption has been shown to occur
from water and oily vehicles (Monteiro-Riviere et al., 2005).
4.4.1.1 The oral route of exposure
Oral exposure to nanoparticles can result from ingestion of nanoparticles in food (either as additives
or as re-engineered protein or lipid clusters, for example), or from food contact materials including
packaging where nanoparticles are proposed to have many uses (see Chapter 2). More indirect
exposure can arise from ingestion of food from animals such as fish and shellfish (i.e., molluscs and
crustaceans), that have taken up nanoparticulate matter, as part of the human diet. For example,
surface sediment- and filter-feeding molluscs are prime candidates for uptake of manufactured
nanoparticles from environmental releases, since the molluscs are already known to accumulate
suspended particle- and sediment-associated conventional pollutants (Galloway et al., 2002 and
Livingstone, 2001). It should also be noted that the specific use of nanotechnology in animal feed
production could potentially result in exposure of humans consuming animal-based products as part
of their diet. However, as already discussed in Chapter 2, there are currently no known applications
of nanotechnology in the animal feed industry, and consequently, human exposure via this route is
considered to be minimal at this time.
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Little is known to date about actual exposure to engineered nanoparticles from food (or other routes),
and even less is known about the likely future exposures. This is in part because measurement
techniques do not allow quantification of nanoparticles, either naturally present or added, in food as
described in Chapter 3. Also, as already discussed in Section 3.4, many food products contain
considerable amounts of anthropogenic (naturally occurring) nanoparticles, such as silica (or even
traces of titanium dioxide), which will make estimation of exposure to deliberately added nanoparticles
difficult.There are some data relating to exposure to microparticulates in food (i.e. particles in the size
range 200nm to 2000nm, which are usually considered as being too large to enter into individual cells).
Lomer et al. estimated that 1012–1014 non-biological, e.g. engineered, particles are ingested per
individual daily from the typical Western diet with an estimated uptake into the body of 0·1–1% (i.e.
109–1012 particles/d) (Lomer et al., 2002). These particles are mainly titanium dioxide (TiO2) and
particulate silicates (including aluminosilicates).The particles are naturally occurring as soil particles but
also are added to food, pharmaceuticals and toothpaste as microparticles (defined as 0·1µm < diameter
< 3µm). In practice, the microparticles observed in the intestinal mucosa are almost always <1µm
diameter.
4.4.2 Measurement of exposure to nanoparticles and derivation of a dose metric
Conventionally, measurement of exposure and consequently dose4 in toxicological studies or
estimation of human exposure via the diet and/or the environment is based on mass concentration,
i.e. exposure to a chemical at a level of mg/kg of food or parts per million (ppm) in air.The use of mass
concentration data alone for the estimation of the dose in toxicological studies with nanoparticles or
in humans following exposure to nanoparticles is regarded as inappropriate, and the number
concentration and/or surface area need to be taken into account (SCENHIR, 2007).This is due to the
fact that, as shown in Table 4.2 and Figure 4.3, these smaller particles occupy less volume, resulting in
a large number of particles with a greater surface area per unit mass and increased potential for
biological interaction (Oberdörster et al., 2005).
Table 4.2  Particle Size and Surface Area (after SCCP, 2007)
4 Estimation of dose is derived by measurement of the level of a “chemical” in food or the environmental milieu (air, water)
followed by an estimate of the amount of food or water consumed or air inhaled over a specified time in order to derive the
actual mass amount of chemical entering the body (the intake).
Particle Diameter (nm) Number of Particles per Total Particle Surface 
Gram of Material Area cm2/gram
1000 1.9 x 1012 60,000
100 1.9 x 1015 600,000
10 1.9 x 1018 6,000,000
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Figure 4.3  Illustration of the Small Mass: Large Surface Area Paradigm
Table 4.2 (after SCCP, 2007) shows that 1 gram of material composed of 10nm particles contains 1
million times more particles than the same material composed of 1,000nm (1µm) particles and the
surface area is 100 times greater. Since the toxicity of nanoparticles, particularly inorganic engineered
particles and carbon nanoparticles, appears to be primarily due to surface reactivity, obviously the
larger the surface area per unit mass, the more potential there will be for toxicity.
Measurement of particle mass is relatively straightforward and, as outlined in Chapter 3, there is a wide
range of physical and chemical characterisation techniques that can be employed to measure
nanoparticles, most of these being suitable only for the “as-synthesised” particle in powder form. It has
already been noted however that routine measurements of free nanoparticles in biological media, in order
to assess exposure and hence dose, is more difficult since suitable equipment is not yet available
(SCENHIR, 2006, 2007).Also, concentrations are often below the limits of detection for instrumentation
such as UV, or there is no parameter that can easily be measured, e.g. fluorescence. In some cases, e.g.
metallic species such as silver, there is elution of a chemical species from the nanoparticles that enables
detection, but this is not always the case. Characterisation of the relationship between exposure to
nanoparticles and biological response may be achieved by labelling of the nanoparticles with a fluorescent
dye followed by image analysis (Yan et al., 2007). Using this approach, it has been shown that silica
nanoparticles are rapidly taken up by a range of different cells (Figure 4.4) and estimates of uptake can be
made (Yan et al., 2007, Lynch, 2008, personal communication).
Total Surface Area
6 cm²
Total Surface Area
60 cm²
(All 1mm cubes)
Total Surface Area
60,000,000 cm²
(All 1nm cubes)
1 cm
1 cm
Total Surface Area
30% Larger Than
a Football Pitch
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Figure 4.4  Confocal Microscopy Image of Lung Epithelial Cells Showing
Significant Nanoparticle Uptake Following Exposure for 24 Hours to
Fluorescently Labelled 30nm Silica Dioxide Nanoparticles (red). Individual Cell
Nuclei are Stained Blue
(Courtesy of Dr I. Lynch, Department of Chemistry, University College, Dublin)
Measurement of the surface area of a given mass of nanoparticles is also difficult, as many of the
current techniques, e.g. nitrogen adsorption, do not distinguish fully between porosity and surface
area.An additional complication is the very ready aggregation of nanoparticles that occurs in biological
media, resulting in larger particles, or even a gradual increase with size as a function of time. Such
aggregation makes it almost impossible to measure either particle number or surface area and to
estimate the actual exposure dose in in vitro and in vivo toxicological studies or in exposed humans.
While the most meaningful dose metric for use in assessing the risk of nanoparticles is probably (in
many cases) surface area and/or particle number, in practice it is recognised that these are extremely
difficult to measure on a routine basis. New approaches need to be developed to their identification
and measurement or, alternatively, nanoparticles need to be specially adapted for specific studies (such
as the fluorescently labelled silica particles used in the studies reported above). This is one of the
major problems facing the scientific community in assessing the potential risks of nanoparticles.
Additionally, effects on nanoparticle aggregation and/or release from the food matrix during digestion
need to be considered, and there are no approaches to address these at present.
It should also be noted, as previously reported by the EU Scientific Committee on Consumer
Products (SCCP, 2007), that there are also research reports in which the relationship between size,
surface area and toxicity is not consistent and it is not always possible to predict effects on the basis
of size or surface area alone (Warheit et al., 2007;Yin et al., 2005).
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4.5 Risk Characterisation 
Risk characterisation as part of the traditional risk assessment model involves a review of the
identified hazards or toxicities, the dose or exposure level at which toxicity is or is not seen and a
comparison of this level with the estimates of human (or environmental) exposure resulting from the
exposure assessment.
A summary of what is currently known regarding the hazards posed by nanoparticles has been
provided in section 4.2 of this chapter. Several of the risk assessment challenges posed by
nanoparticles have been highlighted, including their large surface area, their potential to induce
oxidative stress, their interactions with biomolecules such as proteins and DNA. Although in vitro
studies with a range of particles, in particular inorganic and other non-biodegradable particles have
shown that particles can be inherently toxic, few in vivo studies have been carried out, particularly using
the oral route of administration, to confirm that the potential in vitro toxicity is manifest in vivo. Based
on theoretical considerations, it is probably unlikely that the toxicity seen in in vitro cell systems will
be expressed in vivo in humans or experimental animals, due primarily to the lack of bioavailability of
many potentially toxic (inorganic) nanoparticles.These in vitro studies are also considered to have little
relevance for the risk assessment of the organic nanoparticles that are the major focus of research
into applications of nanotechnology in the agrifood sector.
Several models have been investigated for the identification of the hazard profile of nanoparticles, such
as the ROS model (Xia et al., 2007), the biomolecule corona model (Lynch, 2007) or the surface area
model (Duffin, 2007). More data are needed, especially in relation to characterisation of the risk posed
by nanoparticles in food.There are a range of additional factors that need to be considered in relation
to nanoparticles in food that would not be detected using classical toxicity tests, since the latter
measure very specific endpoints that may not be the only ones of relevance.
The specific hazard issues relating to food include (i) the increased bioavailability of nanoparticles
compared with the macroforms of the same material; (ii) the potential role of nanoparticle-induced
ROS in inflammatory digestive diseases such as IBS and Crohn’s disease (for which there are classical
tests which are also applicable to nanoparticles); (ii) the potential effects of nanoparticles on protein
and enzyme stability and functionality whereby the metabolic processes may be disrupted, and/or
nutrient bioavailability may be altered; (iii) the potential effects of storage, heating/and ageing on
nanoparticle-biomolecule complexes in food, and perhaps others as yet unrecognised.
There is limited knowledge concerning the bioavailability and toxicokinetics of nanoparticles following
exposure via the diet or the oral route.The size, shape and composition of particles will have a major
effect on their bioavailablity and toxicokinetics, as will their surface modification by, for example,
adsorption of proteins and other endogenous molecules, their surface charge, aggregation and rate of
dissolution or degradation.
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The exposure considerations outlined in 4.4 have shown that there are many gaps in knowledge
regarding exposure to nanoparticles via the food chain.The exposure metric is of major importance
in assessing the dose of nanoparticles producing toxicity (hazard characterisation) and hence the risk
of nanoparticles in the body as well as the environment, and to date there is no clear consensus on
how exposure to nanoparticles should be measured.
In relation to the possible risks of nanoparticles in food and feed, many food and feed ingredients are
comprised of biopolymers, e.g. proteins, carbohydrates and fats with sizes extending down to the
nanoscale. Consumers are therefore already exposed to natural nanoparticles in their diet, without
any recognised adverse effect. It can be generally assumed that natural ingredients/substances in the
human or animal diet such as lipids and proteins that have been produced either partially or wholly
by nanotechnology will be processed normally and catabolised in the body. These natural
ingredients/substances are unlikely to present a risk to health, even when the proportion of
nanoparticulate material in the diet is increased by nanoengineering production methods.
The nanoforms of natural ingredients/substances may however show increased bioavailability or be
able to penetrate to parts of the body normally inaccessible to the macro form. Increased
bioavailability of essential nutrients such as minerals and vitamins or the transformation of a normally
lipid-soluble molecule to a water-soluble form via nanoengineering may have profound effects for
cellular biochemistry and consequent perturbations of physiological processes.Anticipated changes in
bioavailability of biologically-active endogenous molecules such as vitamins and hormones on moving
to the nanoscale needs further investigation before the technology is more widely introduced, as they
have profound implications for concepts such as Safe Upper Level (SUL) and Recommended Daily
Allowance (RDA) for vitamins.The same applies to the Acceptable Daily Intake (ADI) established for
food additives and other food chemicals potentially found in food.
The lack of knowledge regarding the effect on pharmacokinetics and bioavailability of changes in the
physicochemical properties of normally inert and non-biodegradable materials such as inorganic
particles, e.g. titanium dioxide, and biological polymers in moving to the nanoscale is of particular
concern, since this will inevitably lead to changes in how they are handled in the body, with potential
cascade effects on cellular homeostasis. From studies conducted to date on the oral uptake and
distribution of such materials, it appears that their physicochemical properties including apparent
insolubility does not guarantee non-absorption of the nanoparticles from the gut.A range of studies
on uptake of nanoparticles from the GIT have demonstrated increased bioavailability of such
materials, but similar research does not appear to have been carried out to date for such particles in
a food matrix. Biopersistence of essentially insoluble nanoparticles following repeated/long term
exposure can be anticipated.
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Conclusion on risk assessment on nanoparticles in the food chain
In considering the possible risks of nanotechnology in the agrifood actor, it must be recognised that
the presence of nanoparticles in food is not a new phenomenon. People have always been exposed to
very fine particles in their diet, without harmful effects, since many food and feed ingredients are
comprised of proteins, carbohydrates and fats with sizes extending from large biopolymers
(macromolecules) down to the nanoscale. Even when food is consumed predominantly as
macromolecules, the natural digestive processes of the body reduce these to the nanoscale in order
to utilise the energy contained in the molecules for the maintenance of physiological processes.
There are however gaps in knowledge regarding the bioavailability of nanoparticles via the oral route,
their handling by the body, the methods that can be used to assess their toxicity and, in particular, the
metrics that can be used to assess exposure. It is therefore difficult at this time to arrive at a fully
informed assessment of the risk from nanoparticles in the food chain.Although the basic principles of
the existing risk assessment model can be applied to nano-based food and feed, current methods for
assessment of toxicity and quantification of exposure require some modification before they can be
applied with confidence for the assessment of nanotechnology in food.
A specific risk assessment for silver nanoparticles, which are finding increasing use as anti-microbial
agents, applying the traditional risk assessment model, has recently been published (Blaser, 2008).An
overview of this risk assessment, which focuses on silver released into the environment from
nanoparticles embedded in a polymer, is presented in Appendix IV of this report. Although this
assessment is not specifically relevant to the assessment of nanotechnology in food, it is nevertheless
of interest, since it does demonstrate that the basic risk assessment model can be applied to
nanoparticles in the same way as other hazards.
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5.1 Introduction
It is recognised that the application of nanotechnology may present new challenges in terms of safety,
regulatory and ethical considerations, while offering many potential benefits to manufacturers and
consumers (Chau et al. 2007).
In terms of current regulatory approaches in the European Union, it is generally considered that
potential uses of nanotechnologies in the food and feed area will be covered by the existing regulatory
framework, either by the principles of the general food law (EC 178/2002) or by specific approval
processes. Major gaps in existing regulations were not identified in a review undertaken by the UK
Food Standards Agency (FSA, 2006), but there is uncertainty in some areas as to whether a number
of specific applications of nanotechnologies would be picked up consistently, for example the
introduction of nanoscale preparations of existing food ingredients, or currently approved food
additives. As food and feed regulations are harmonised at EU level, any action to address such
uncertainties would need to be taken forward by the European Commission. A review recently
completed by the Commission has indicated that the existing EU legislation is broadly adequate to
cover potential risks of nanotechnology-based products, although in some areas, specific supporting
instruments (guidelines, test protocols, standards) may need to be developed and some provisions
clarified or adapted, in order to ensure the full effectiveness of the existing legislation in practice (EC,
2008).
Approval processes are in place for a large number of food ingredients and agents used in food and
feed manufacture and processing, including novel foods and novel food processes, food additives and
flavourings and food packaging materials.These agents must meet the requirements of the approval
system before being permitted for use, and it is anticipated that the majority of nanomaterials in food
will fall into this category. The following sections briefly outline the current applicable regulatory
framework.
5.2 Provisions of the General Food Law
Under general food law, “unsafe food” (as defined in Article 14, Reg. (EC) 178 of 2002) cannot be
placed on the market.
This requirement has been enacted in Ireland by three Statutory Instruments. S.I. No. 747 of 2007
European Communities (General Food Law) Regulations, 2007 covers retail food business
establishments and those processing food of non-animal origin. S.I. No. 910 of 2005 European
Communities (food and feed hygiene) Regulations, 2005 as amended by S.I. No. 387 of 2006, covers
food business establishments requiring approval engaged in the handling and processing of products
of animal origin and S.I. No. 335 of 2006 European Communities (Hygiene of Fishery Products and
Fish Feed) Regulations, 2006 covers food business establishments requiring approval and engaged in
the handling and processing of fish and shellfish.
5. LEGISLATION
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Similar provisions are applicable to packaging materials and requirements are laid down in Regulation
(EC) 1935/2004 which is enacted in Irish food law by the European Communities (Plastics and other
materials) (Contact with food) Regulations, 2007 (S.I. No. 587 of 2007).
The general hygiene provisions which apply to most food business operations are the European
Communities (Hygiene of Foodstuffs) Regulations, 2006 S.I. No. 369 of 2006 and, in the case of feed
business operators, the European Communities (Food and Feed Hygiene) Regulations, 2005 S.I. No.
910 of 2005. Under these regulations, there is a general obligation on food and feed business to carry
out their activities in accordance with HACCP principles.These include identifying the points in those
operations where food hazards may occur, and identifying and implementing effective measures to
control the hazards at these critical points.These obligations will apply to the use of nanoparticles in
food production and processing as they do to any other hazard identified in the food chain. It is
recognised however, that there is a need for risk managers, including food business operators, to be
made more aware of their responsibilities under food law in relation to the specific applications of
nanotechnology in the food and feed industries, and the difficulties that may be involved.
5.3 Novel Foods and Processes
Foods produced by the application of nanotechnology and/or containing nano-ingredients may be
considered as “novel foods”, falling within the scope of the novel food legislation and hence requiring
prior approval before placing on the market.The Novel Food Regulation (EC) No 258/97 applies to
foods or food ingredients that have not been consumed to a significant degree within the EU before
15 May 1997. In addition, Article 1. 2.(f) brings into the scope of this Regulation food and food
ingredients to which a new process has been applied that gives rise to significant changes in
composition or structure that in turn affect the nutritional value, metabolism or level of undesirable
substances. The FSAI is the competent authority for the enforcement of novel food legislation in
Ireland.
The review of the Novel Food Regulation is ongoing and in the proposed replacement legislation,
nanotechnology is specifically mentioned as an example of one of a number of emerging food
production processes that may require novel food authorisation prior to marketing. On February 6th,
2008, the Finnish customs authorities became the first in the EU to reject the import of a food
supplement on the basis that it breached the Novel Food Regulation. The product “Lypo-sphericTM
Vitamin C” from the USA was claimed, on the packaging, to provide increased bioavailability of vitamin
C due its encapsulation in liposomal nano-spheres.The Finnish authorities declared it a novel process
and, therefore, the product as a novel food as yet unauthorised in the EU.
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The novel food authorisation process requires that a safety assessment is carried out by a Member
State which is then reviewed by all other Member States.Where even one Member State objects to
the marketing of the novel food, an additional assessment is requested from EFSA prior to the
Commission drafting a Decision to authorise or reject the product.The safety assessment addresses
composition, nutritional value, intake, toxicology and allergenicity among other issues.While particle
size per se is not a criterion that could be used to determine the novelty of a food or food ingredient,
any effect on the composition, nutritional value, metabolism and intended use of a product could bring
particle size into consideration.
Where there is disagreement, Article 1.3 makes it possible for the Commission, in association with
the Standing Committee for the Food Chain and Animal Health (SCFCAH), to decide whether a food
or ingredient falls within the scope of the Novel Food Regulation.
Where new evidence comes to light, calling into question the safety of an authorised novel food, a
Member State may temporarily suspend its marketing and notify the Commission and other Member
States. The Commission will subsequently examine the veracity of the concerns and decide, in
association with Member States, the measures to be taken, if any.
In the event that a nano-ingredient falls outside the scope of the Novel Food Regulation, the general
safety articles of the EU Food Law Regulation (178/2002) would apply, which require that food placed
on the market is safe.
5.4 Food and Feed Additives
The use of food and feed additives in the EU is controlled by European Parliament and Council
legislation, which sets out lists of permitted additives, the foods in which they can be used, and
maximum levels of use. All permitted additives have been assessed for safety by the independent
Scientific Committees that advise the European Commission, a role now performed by EFSA. In
addition, each additive must comply with specific purity criteria laid down in corresponding European
Commission Directives. The criteria dictate the chemical structure and purity of each additive.
However, minimum particle size is only specified in the case of microcrystalline cellulose (E460 (i)),
while the specification for carrageenan (E407) limits the molecular weight distribution (which may
indirectly limit particle size).
As only the specifications for two additives limit the size of particles, it could be argued that in
principle there are potential gaps in the legislation with respect to the use of food additives in
nano-form. However, individual specifications may be amended at SCFCAH. Therefore, action
could be taken relatively quickly if it is deemed necessary that amendments were required to
address the issue of particle size, whether as a result of an assessment undertaken by EFSA, or
on the basis of information supplied by, or a request from, a Member State.
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Positive lists control the use of miscellaneous food additives, colours, sweeteners and smoke
flavourings in EU Member States.Any new nanomaterials would need to undergo safety assessments
by EFSA before they can be included on the relevant positive list and so be permitted to be used in
foods. For the majority of additives, specifications have also been elaborated for the material as used,
however as noted above, these currently only specify minimum particle size for two additives.
During recent negotiations in Brussels on the package of proposals to replace and update the current
legislation on food additives, flavours and enzymes it has been agreed that an additive should require
re-evaluation or re-approval if it is prepared in a form that is different from that originally assessed
and approved.A change in particle size (i.e. preparation in “nano” form) is given as an example of such
a difference. It is anticipated that these new Regulations will be adopted by the end of 2008 and will
come into force in all Member States shortly afterwards.
5.5 Food Contact Materials
This is the area where commercial applications of nanotechnology seem to be the most advanced, as
evidenced by the fact that EFSA has already published an opinion on the safety of a nanoscale silicon
dioxide coating (less than 100nm), to be used in plastic packaging behind an inner layer of PET plastic
to provide gas barrier properties (EFSA, 2007). In addition, a safety evaluation for a titanium nitride-
based nanoparticle to be used as a food contact material additive is currently being undertaken by
EFSA. Current controls in the area stem mainly from Regulation (EC) 1935/2004 on materials and
articles in contact with food, and those that might reasonably be expected to transfer their
constituents to food. It is considered that this legislation is sufficiently wide-ranging to regulate the
migration of nanoparticles into food from food contact materials.
Alternatively, where the nanoscale component might be intended to migrate into the food as part of
an ‘active’ packaging system, it must only do so to improve the shelf-life or to maintain or improve the
condition of the food. However, any change to the food must comply with EC provisions applicable to
food, and the packaging must be labelled as ‘active’.
Some materials and articles are subject to additional, specific measures, such as plastics,
ceramics and regenerated cellulose film, and different specific requirements may apply to
nanomaterials incorporated into these materials.
Whilst current legislation appears to be wide-ranging enough to cover products derived from
nanotechnology in general terms, it does not specifically differentiate between conventional chemicals
and those produced using nanotechnology. Draft proposals are currently being discussed that could
regulate, should the need arise, particular materials, such as those derived from nanotechnology, that
are not specifically covered by existing legislation.
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A further potential solution would be for the Commission to amend Annex I of European Regulation
(EC) 1935/2004 to require that all nanomaterials are subject to risk assessment.This would bring all
such substances within scope of the Regulation, regardless of the material into which they are
incorporated. This would also apply to those materials and articles not already covered by specific
measures already in place.
In addition to the above mentioned controls, urgent consideration needs to be given to the
control/fate of nanoparticles that are present in food contact materials intended to be recycled for
further food use.A Commission Regulation on recycled food contact materials (Reg. No. 282/2008)
has recently been adopted, which requires the authorisation of recycling processes following a risk
assessment by EFSA. Nano-particle-containing food contact material would fall under the scope of this
Regulation.
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The presence of nanoparticles in food is not a new phenomenon. People have always been exposed
to very fine particles in their diet, without harmful effects, since many food and feed ingredients are
comprised of proteins, carbohydrates and fats with sizes extending from large biopolymers
(macromolecules) down to the nanoscale. Even when food is consumed predominantly as
macromolecules, the natural digestive processes of the body will reduce these to the nanoscale in
order to utilise the energy contained in the molecules for the maintenance of physiological processes.
The applications of nanotechnology in food production reviewed in this report must therefore be
viewed against this background exposure to natural nanoparticles in the diet.
The potential applications of nanotechnology range from modifications of the organic (protein,
carbohydrate and fat) molecules that form part of the normal diet, to achieve added or altered
functionality, to the use of inorganic nanoparticulate materials in food packaging or as food ingredients,
including food additives. Nanotechnology is a new area of science and the advantages and limitations
of its use in the agrifood sector are not fully understood at this time.This brings with it new challenges
for food and feed safety due to the diversity of the technology behind nano-enhanced food products
in the market place.This report has sought to explore the applications of nanotechnology in the food
and feed industry, to characterise the current state of knowledge on the possible risks of nanoparticles
in food and to examine the existing regulatory framework on food safety in relation to its adequacy
to protect the health of consumers from such possible risks.
The report has identified that there are many potential applications of nanotechnology in the food and
feed industry. These range from minor modifications of natural food ingredients to enhance taste,
palatability and other properties, to more major modifications that may result in altered handling of
such ingredients in the body, including increased bioavailability of essential nutrients. Applications of
nanotechnology in agriculture such as pesticides and water purification may also impact on food
indirectly through residual presence in plant materials and water. It has been suggested that the
distinction between nanotechnology and non-nanotechnology in the food and feed industry should be
determined by whether the particular ingredient is man-made, i.e. "man-made components modified
at a molecular or super-molecular level", or natural.
Organic nanomaterials (nanoparticles of natural food ingredients), whether physically or chemically
constructed, are likely to be one of the main areas of interest in the agrifood sector in respect of
incorporation of nanotechnology into foods.The predominant food-related area for short term future
exploitability of nanoscience is food packaging, while, in the longer term, nanoscale research in foods
appears to be focused on ‘programmable’ release of organic nanoscale encapsulated food ingredients
or nutrients.The use of nanoscale technologies for alteration of food stability and texture is also of
current interest.
6. DISCUSSION
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This report has identified that currently there appears to be no direct use of complex inorganic
nanoparticles such as carbon nanotubes in foods. Simple inorganic molecules like titanium dioxide and
clay particles are being used in packaging and may have potential to migrate into foods. Nanomaterials
are present in foods that are currently available on the market, mostly through internet trading, mainly
in the form of simple nanoscale encapsulated functional ingredients.
The assessment of the borderline between nanotechnological manipulation of food and feed or
conventional food engineering will present considerable difficulties. An example is enzymatic
functionalisation, whereby an enzyme is used to modify a food structure to give it a new attribute.This
cannot be considered to be new technology, however, if the food structure presented for modification
is a nanoparticle encapsulating a non-organic compound, then this application will fall under the
definition of nanotechnological manipulation.There is a need for a clear and widely accepted definition
of nanotechnology that differentiates between the use of nanoscale technologies in food and feed
production and the actual inclusion of nanoparticles in food. It will be essential to establish systems
for the identification, categorisation and assessment of food and feed which is based on or has come
into contact with nanotechnology-based technologies.
A further aspect that may need consideration in relation to applications of nanotechnology in the
agrifood sector is the fact that nanoparticles in food will be exposed to a range of storage and use
conditions. For example, they could be used in products that are stored at low temperatures and then
heated for consumption.This may affect the nanoparticle stability within the food and also change the
properties of the biomolecules in the food, and potentially how these interact with the nanoparticles.
To date there is no literature dealing with this.
In relation to the possible risks of nanoparticles in food and feed, such particles are still largely an
unknown quantity in terms of how they will behave in the body.As already indicated, many food and
feed ingredients are comprised of biopolymers, e.g. proteins, carbohydrates and fats with sizes
extending down to the nanoscale. Consumers are therefore already exposed to natural nanoparticles
in their diet, without any recognised adverse effect.
There is limited knowledge concerning the bioavailablity and toxicokinetics of nanoparticles, following
exposure via the diet or the oral route.The size, shape and composition of particles will have a major
effect on their bioavailablity and toxicokinetics, as will their surface modification, e.g. by adsorption of
proteins and other endogenous molecules, their surface charge, aggregation and rate of dissolution or
degradation.
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While it can be generally assumed that natural ingredients/substances (such as lipids and proteins) in
the human or animal diet that have been produced either partially or wholly by nanotechnology will
be processed normally and catabolised in the body, the nanoforms may show increased bioavailability
or be able to penetrate to parts of the body that are normally inaccessible to the macro form.
Increased bioavailability of essential nutrients such as minerals and vitamins or the transformation of
a normally lipid-soluble molecule to a water-soluble form via nanoengineering may have profound
effects for cellular biochemistry and consequent perturbations of physiological processes. It may not
be appropriate to compare intake of such modified nutrients with existing safety- and health-based
threshold values that have been developed based on the natural form of nutrients and their natural
bioavailabilities.
The lack of knowledge regarding the effect on pharmacokinetics and bioavailability of changes in the
physicochemical properties of normally inert and non-biodegradable materials such as inorganic
particles, e.g. titanium dioxide, and biological polymers in moving to the nanoscale is of particular
concern since this will inevitably lead to changes in how they are handled in the body, with potential
cascade effects on cellular homeostasis. From studies conducted to date on the oral uptake and
distribution of such materials, it appears that their physicochemical properties including apparent
insolubility do not guarantee non-absorption of the nanoparticles from the gut.A range of studies on
uptake of nanoparticles from the GIT have demonstrated increased bioavailability of such materials,
but similar research does not appear to have been carried out to date for such particles in a food
matrix. Biopersistence of essentially insoluble nanoparticles following repeated/long term exposure
can be anticipated.
There is also limited knowledge concerning the intrinsic toxicity of nanoparticles.While a range of in
vitro screening tests designed to predict the toxicity of nanoparticles have been developed, few in vivo
studies in animals have been carried out, particularly via the oral route which is the only relevant route
for prediction of risks in food.There is an urgent need to develop predictive and validated tests that
can be used to screen for the potential hazards of nanoparticles. Nanoscale proteins formed from re-
engineered macromolecules are considered unlikely to be a source of toxicity but may form
anomalous protein assemblies or could induce other proteins to aggregate or fibrillate.This requires
further investigation.
Little is known about interactions of nanoparticles with components of food and potential effects on
toxicity, nor about the influence of possible changes in the nanoparticles following passage through the
digestive system, absorption, distribution and clearance from the body. The aggregation of
nanoparticles that has been observed under laboratory conditions, and which causes major problems
in the characterisation of the size and surface area of the particles, is as likely or more likely to occur
when nanoparticles are incorporated in a food matrix, food packaging or other applications.This has
profound implications when it comes to determining likely exposure via food and/or predicting
potential toxicity, based on extrapolation from in vitro tests or in vivo tests using routes other than
dietary exposure.
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The dose metric is of major importance in assessing the risk of nanoparticles in the body as well as
the environment.The use of mass concentration data alone for the expression of dose in toxicology
testing is insufficient, and the number concentration and/or surface area needs to be taken into
account, as well as the aggregation state as discussed above. There is a wide range of physical and
chemical characterisation techniques that can be employed to measure nanoparticles and the advent
of such techniques has accelerated research and advancement of applied nanotechnology. Equipment
that enables routine measurements in various media for representative exposure to free nanoparticles
is however not yet available.While the most meaningful dose metric for use in assessing the risk of
nanoparticles is probably (in many cases) surface area and/or particle number, in practice it is
recognised that this is extremely difficult on a routine basis. This is one of the problems facing the
scientific community in assessing the potential risks of nanoparticles.
This report has identified that, although the basic principles of the existing risk assessment model
can be applied to nano-based food and feed, in practice there are some gaps in knowledge regarding
the bioavailability of nanoparticles via the oral route, their handling by the body, the methods that
can be used to assess their toxicity and in particular the metrics that can be used to assess exposure.
At this point in time it may not be possible to produce a meaningful risk characterisation and
therefore such exercises are more focused at highlighting the possible issues and the areas that
require more research. Current methods for assessment of toxicological issues and quantifying
exposure require some modification before they can be used for nanoparticles. Until such time as
there is further knowledge concerning the many applications of nanotechnology and broad
international agreement concerning the approaches to be used in assessing the risks, each application
of nanotechnology in food and feed production and the wider implications of nanotechnology for the
food chain will need to be assessed on a case-by-case basis. As a consequence, risk management
approaches to foods resulting from nanotechnology will necessarily be precautionary.
In terms of the existing legal framework, current legislation does not contain specific provisions
on nanomaterials. The potential uses of nanotechnology in the food and feed area are however
covered either by the principles of general food law or by specific approval processes such as
those for food additives, food contact materials, novel foods, pesticide and biocide approval
systems. Indeed, specific controls on the use of nanotechnology in the production of food additives
are expected to be adopted at EU level by the end of 2008.
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A key issue is whether assessment of the risk of nanotechnology-based food and feed should be
primarily the responsibility of the food business operator or whether there should be a requirement
for a regulatory evaluation and approval system.The many potential applications of nanotechnology in
the food, feed and other industries could have the potential to swamp current regulatory approval
systems.This report considers that it would be a failure of “duty of care” for food companies intending
to introduce nano-sized food ingredients and/or to change the natural balance of particulate size to
achieve a new functionality, not to conduct an assessment of potential risk of the technology, given
that it is a legal requirement for food business operators to only place safe food on the market and
that safety must be demonstrable. At present, the lack of data regarding the safety of some
nanoparticles in food would imply that a full risk assessment should be conducted.
Food ingredients produced by nanotechnology that are covered by specific approval processes at EU
level, such as food additives and food contact materials, will require a re-evaluation (by the European
Food Safety Authority, via the centralised application system), where there is an existing authorisation
for the non-nanoform, but where presentation in the nanoform is expected to alter the behaviour of
the ingredient in the human body, e.g. in terms of toxicity, or bioavailability.Where a novel food has
been produced via the application of nanotechnology, this will similarly be expected to be evaluated
for its possible risk to health before being placed on the market.The issue of what percentage of a
food (for instance, 5%, 10% or 50%?) should be at nanolevel for it to be defined as having been
produced by nanotechnology must also be taken into account. In relation to food ingredients that are
considered to be natural ingredients in the human or animal diet but which have been produced either
partially or wholly by nanotechnology, e.g. lipid micelles or emulsions, this report considers, as already
indicated, that the responsibility for ensuring safety for consumers rests primarily with the food
business operator, based on an assessment of the possible risks and likely exposure patterns.
It is recognised however that implementation of these principles will be difficult in many areas, as
current methodologies for identifying hazards and evaluating risks may not necessarily fully allow the
specific properties of nanoscale substances to be taken into account. Scientifically, valid new methods
for assessing the use of nanotechnology in food are needed.
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The FSAI Scientific Committee has considered the current state of knowledge regarding the
applications of nanotechnology in the food and feed industry, the possible risks of nanoparticles in
food and feed and the existing regulatory framework on food safety in relation to its adequacy to
protect the health of consumers.
In relation to current and future applications of nanotechnology in the food and feed industry, the
Committee concludes that:
• nanotechnology has the potential to have a major impact on food innovation over the coming
decades, with many new applications foreseen in the agrifood sector for the benefit of
consumers and the environment
• nanoparticulate forms of natural food ingredients are the predominant area of current interest
to the agrifood sector, in respect of incorporation of nanotechnology into foods
• in the area of food research, food contact materials, including packaging, are most likely to
receive the greatest attention in the short term, while ‘controlled’ release of nanoscale-
encapsulated food ingredients or nutrients may be the focus in the longer term.The use of
nanoscale technologies for alteration of food stability and texture is also of current interest
• although the primary focus in food nanotechnology will be on endogenous organic molecules,
e.g. proteins, lipids, carbohydrates, non-degradable inorganic nanoparticles such as titanium
dioxide and clay particles are likely to be used in packaging and other applications and may
have the potential to migrate into foods
• although the deliberate use of other engineered, non-biodegradable nanoparticles such as
carbon nanoparticles, e.g. fullerenes and carbon nanotubes, in foods has not been reported,
they may inadvertently enter the food chain 
• foods containing nanomaterials are available on the global market, mainly through internet
trading. Regulatory controls on such products for personal use are recognised to be deficient,
and FSAI and other food safety bodies in Europe do not have full enforcement powers in
relation to them
• nanosensors are being developed for the purpose of food surveillance, including traceability.
Current research is focused on the incorporation of nanosensors into food packaging
materials for tracking, safety and biosecurity purposes and on the development of rapid
biosensors for the diagnostic detection of pathogens/contaminants in foods and their
surrounding environment.
7. CONCLUSIONS AND RECOMMENDATIONS
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In relation to the assessment of possible risks of nanoparticles in food and feed, the Committee
considers that a number of difficulties and gaps exist which hamper the application of current risk
assessment methodologies to the use of nanotechnology in food and feed production.These include:
• the lack of robust methods for the characterisation and measurement of nanoparticles in
food, feed and other biological matrices
• consequent difficulties in assessing exposure to nanoparticles and in ensuring metrological
traceability
• deficiencies in the knowledge base regarding the bioavailability and possible toxicity of
nanoparticles, and their behaviour at the cellular level
• an absence of standardised protocols for the assessment of the toxicological profiles of
nanoparticles in vitro and in vivo.
Some modification of current risk assessment approaches and methodology is therefore necessary, in
order to provide more informative characterisations of risk, although the basic model of hazard
identification, hazard characterisation, exposure assessment and risk characterisation would appear to
be adequate and applicable to nanotechnology.
In particular, the Committee considers that potential increases in the bioavailability of essential
nutrients resulting from the application of nanotechnology will require a reassessment of the
applicability of traditional threshold values developed for safety and health purposes.
The Committee also recognises that little is known concerning the potential for nanoparticles to
migrate into the environment following disposal and/or recycling of articles such as food contact and
other nanoparticle-containing materials. Nanoparticles released in this way may enter the food chain,
with consequent unrecognised exposure of consumers. In addition, nanoparticles may migrate into
foods from recycled packaging produced from material that contains nanoparticles.
The Committee concludes therefore that, until these issues are addressed and a standardised
approach is developed for the assessment of the possible risks of nanoparticles in food and feed, at
the level of the European Community and internationally, each application of nanotechnology in food
and feed production and the wider implications of nanotechnology for the food chain will need to be
assessed on a case-by-case basis.
On risk management measures, including the legal framework for ensuring food and feed safety, the
Committee considers that although current legislation does not contain specific provisions on
nanomaterials, potential uses of nanotechnologies in the food and feed area are broadly covered either
by the principles of the general food law or by specific approval processes such as those for food
additives, food contact materials and novel foods. Opportunities for strengthening the European
Community legislation have however been identified in this and other reports.
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The Committee also considers that, within this legal framework, it is the primary responsibility of food
business operators to assess the possible risks and take all necessary steps to ensure that food is safe
and healthy when applying nanotechnology in food or feed production, whether this involves
introduction of new nanoparticles into foods and packaging or merely manipulation of the size
distribution of natural food molecules in food matrices.
In relation to communication of information regarding the application of nanotechnology in food and
feed, the Committee identifies a need for risk managers, including food business operators, to be made
more aware of their responsibilities under food law in relation to the specific applications of
nanotechnology in the food and feed industries, and the difficulties that may be involved. The
Committee also recognises the importance of keeping consumers and the general public fully
informed regarding the applications of nanotechnology in food.
The FSAI Scientific Committee therefore recommends that:
• when applying nanotechnology in food or feed production, food business operators should
assess the possible risks and take all necessary steps to ensure that food is safe
• the FSAI should communicate with and advise food business operators in relation to their
responsibility to conduct risk assessments on all foods utilising nanotechnology
• to this end, FSAI should keep under review advances in the science of nanotechnology, risk
assessment approaches and the legal framework governing the application of nanotechnology
in food and feed
• the FSAI should promote the establishment of a publicly-accessible inventory of
nanotechnology-based food products and food contact materials, available both at European
Community level and specifically on the Irish market 
• where nanoparticles are incorporated in food or food packaging, EC labelling provisions
should require that such products are labelled to provide this information 
• legal provisions should be considered at EC level to ensure that food and feed ingredients
produced via the application of nanotechnology are specifically controlled to ensure that
where the properties are changed/re-engineered to the nanoscale, they should be re-evaluated
in terms of safety 
• urgent consideration should be given to whether additional controls are required on the
disposal and/or recycling of nanoparticle-containing food contact and other materials
• food surveillance programmes should include investigation of the potential for nanoparticles,
particularly inorganic molecules such as titanium dioxide and clay particles used in packaging,
to migrate into foods and also to be recycled in the environment and enter the food chain
indirectly.
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The Committee also recommends that research at national level, with application of targeted funding,
should urgently be undertaken to increase the reliability of the risk assessment of nanotechnology in
food, including on the following issues:
• the feasibility of establishing an inventory of food and feed products and packaging involving
the application of nanotechnology on the market in Ireland
• development of methods to ensure traceability of nanoparticles in the food chain and
procedures for the characterisation and measurement of nanoparticles in food
• methods for the safe and effective disposal of used, unused or waste nanoparticles 
• the bioavailability and fate of nanoparticles within the human body and animals 
• development of methods to investigate the potential toxicity of nanoparticles in vitro and in
vivo and the underlying mechanisms of nanoparticle toxicity
• the stability/lability of nanoparticles in various foods and their potential interactions with food
components.
Finally, recognising the importance of a coordinated national approach between Government
departments and national agencies on the evaluation of the impact of nanotechology, the Committee
recommends that the FSAI should initiate contacts with other such bodies, to inform them of the
FSAI’s work in this area and to ascertain whether similar initiatives are ongoing elsewhere.The FSAI
should also keep Irish industry informed of developments concerning the applications of
nanotechnology in food and the legal requirements governing such uses.
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ADME Absorption/bioavailability, Distribution, Metabolism, Excretion 
AFM Atomic Force Microscopy
CBEN Centre for Biological and Environmental Nanotechnology 
CDS Circular Dichroism Spectroscopy 
CFM Chemical Force Microscopy 
CNT Carbon Nanotubes
COC Committee on Carcinogenicity of Chemicals in Food Consumer Products and the
Environment (UK)
COM Committee on Mutagenicity of Chemicals in Food Consumer Products and the 
Environment (UK)
CoQ10 Coenzyme Q10
COT Committee on Toxicity of Chemicals in Food Consumer Products and the
Environment (UK)
DEP Diesel Exhaust Particles
DHA Docosahexaenoic Acid
DLS Dynamic Light Scattering 
DSC Differential Scanning Calorimetry
EDXS Energy Dispersive X-ray Spectroscopy 
EELS Electron Energy Loss Spectroscopy
EFSA European Food Safety Authority
EPA Eicosapentaenoic Acid 
EPR Electron Paramagnetic Resonance 
ESA Electroacoustic Sonic Amplitude
ESR Electron Spin Resonance 
FRET Fluorescence Resonance Energy Transfer 
FFF Field Flow Fractionation
FSAI Food Safety Authority of Ireland
FTIR Fourier Transform Infrared Spectroscopy
GIT Gastrointestinal Tract
GM Genetically Modified
HEK Human Epidermal Keratinocytes
IBD Inflammatory Bowel Disease
ICP-MS Inductively Coupled Plasma Mass Spectrometry
ITC Isothermal Titration Calorimetry
LEED Low Energy Electron Diffraction
MALDI Matrix-Assisted Laser Desorption Ionization
MFM Magnetic Force Microscopy
MMP-9 Matrix Metalloproteinase 9
MWCNT Multi-Wall Carbon Nanotubes
NIOSH National Institute of Occupational Health (USA)
APPENDIX I: ABBREVIATIONS
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NLC Nanostructured Lipid Carriers
NMR Nuclear Magnetic Resonance Spectroscopy
NPs Nanoparticles
NSLS Nano-sized Self-assembled Liquid Structures
O/W Oil-in-Water
PM10 Particles of 10 micrometres or less
PP Peyer’s Patches
QD Quantum Dots
USFDA US Food and Drug Administration
IL Interleukin
ISO The International Standards Organization
IV Intravenous
PCS Photon Correlation Spectroscopy
PET Polyethylene Terephthalate
PLGA Polylactide-co-Glycolide
PMMA Polymethyl Methacrylate
RFID Radio Frequency Identification
ROS Reactive Oxygen Species
RT-PCR Real-Time Polymerase Chain Reaction
SANS Small Angle Neutron Scattering
SAXS Small Angle X-Ray Scattering
SC Stratum Corneum
SCFCAH Standing Committee for the Food Chain and Animal Health
SCCP Scientific Committee on Consumer Products
SCENIHR Scientific Committee on Emerging and Newly Identified Health Risks
SEM Scanning Electron Microscopy
SERS Surface Enhanced Raman Spectroscopy
SLN Solid Lipid Nanoparticles
SMS Single Molecule Spectroscopy
SNOM Scanning Near Field Optical Microscopy
STM Scanning Tunnelling Microscopy
TEM Transmission Electron Microscopy
TiO2 Titanium dioxide
TIRF Total Internal Reflectance Fluorescence
TNF alpha Tumour Necrosis Factor alpha
ToF-MS Time-of-Flight Mass Spectrometry
W/O Water-in-Oil
XPS X-ray Photo electron Spectroscopy
XRA X-Ray Absorption
XRD X-Ray Diffraction 
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ADI
The amount of a substance present in food that
can be consumed daily for an entire lifespan
without appreciable risk.
Aggregate 
Larger particles formed through agglomeration
or aggregation of primary particles (the smallest
identifiable subdivision in a particulate system), in
which the various components are not easily
broken apart.
Agrifood Sector 
A term describing industries involved in the mass
production, processing, and inspection of food
and animal feed products made from agricultural
commodities
Antioxidant
A chemical which slows or prevents oxidation
(the reaction of substances and/or cell
components with oxygen in a process that can
lead to their breakdown). Oxidative stress can
damage cells.
Bioavailability
The amount of a substance/material absorbed by
the body from the site of first exposure, e.g. the
gastrointestinal tract, to reach the systemic blood
circulation and the rest of the body.
Biocide
A substance used mainly as an anti-microbial
agent.
Biomolecule
A chemical compound found in living organisms
and which is composed predominantly of carbon,
hydrogen, oxygen, nitrogen, sulphur and
phosphorus.
Biopolymer
Any polymer (a long repeating chain of atoms)
found in nature. Examples include starch, proteins
and DNA.
Biosensor
A sensor that incorporates a biologically active
interface, e.g. DNA, protein etc.
Carbon Nanotubes
nanoparticles consisting of one or several
graphene sheets rolled up to form a single- or
multi-walled tube.
Chemical Reactivity and Bioactivity
The chemical reactivity and bioactivity of a
nanoparticle that affects the particle stability and
dispersion properties as well as the particle’s
mobility in biological systems.
Colloid
a substance consisting of particles not exceeding
1µm dispersed in a fluid.
Crohn’s Disease
A chronic inflammation of the gastrointestinal
tract that can lead to cancer.
Dispersion/Aggregation State 
(see also “aggregate”)
The tendency of suspensions of nanoparticles to
aggregate, the process where small molecules or
particles can come together to form a secondary
larger particle or cluster.
Dose
The quantity of nanomaterial absorbed and/or
internalised into the cell.
APPENDIX II: GLOSSARY 
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Emulsion
A suspension of small globules of one liquid
within a second liquid.
Endogenous
A substance, e.g. protein, carbohydrate, lipid, that
originates from within an organism, tissue, or cell.
Encapsulation
A process in which particles or droplets are
coated to create capsules.
Engineered Nanoparticle
A material purposely synthesised or
unintentionally produced and having novel
functional properties exhibited on the nanoscale.
Fullerene (‘buckyball’)
A closed cage pure carbon molecule. The
smallest stable fullerene is the
buckminsterfullerene or buckyball which is
composed of 60 atoms of carbon and has a shape
similar to a hollow soccer ball or a geodesic
dome.
Granuloma
A small mass or nodule of chronically inflamed
tissue that is usually associated with an
inflammatory process or injured tissue, for
example as seen in Crohn’s disease, sarcoidosis
etc.
Hydrophobicity and Solubility
A term describing the degree of wettability of
nanoparticles, a property crucial in assessing the
biological impacts of the particle.
In silico 
An experiment performed via computer
simulation
In vitro
An experiment performed in a test tube or
culture.
In vivo
An experiment performed in a living organism.
Liposome
An oily, microscopic-sized capsule designed to
package and deliver biological cargo, such as
drugs, to cells in the body.
Macrophage
A large immune cell that envelopes invading
pathogens and other foreign material.
Metrological Traceability
The property of a measurement which relates a
result to a stated metrological reference through
an unbroken chain of calibrations or
comparisons, each contributing to the stated
measurement uncertainty. The stated
metrological reference may be a measurement
procedure, or a physical standard.
Micelle
An aggregate of molecules, where in an aqueous
solution the hydrophilic (water loving) head
regions form a protective barrier around the oil
containing hydrophobic (water hating) tail
regions in the micelle centre.
Mucosa
The moist layer that lines the mouth and
gastrointestinal tract.
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Nano-composite
A material that is created by mixing nanoparticles
into a base material.
Nanometre (nm)
One thousand millionth of a metre.
Nano-objects
The generic term of 'nano-object' includes
nanoparticles and their aggregation at nanoscale,
nano-systems, nano-materials, nano-structured
materials and nano-products
Nanoparticle
An ultrafine particle with at least one dimension
between 1 – 100 nanometers (nm).
Nanoparticle Purity 
Nanoparticle samples may contain a range of
impurities such as solvent residues and catalyst
particles (which can also be on the nanoscale).
These impurities vary considerably from batch to
batch and as a result characterisation of the
impurities can be time consuming and difficult.
Nanotechnology
The control of matter and processes at the
nanoscale, typically, but not exclusively, below 100
nanometres in one or more dimensions where
the onset of size-dependent phenomena usually
enables novel applications.
Nanotubes
A molecule that resembles a cylinder with at
least one dimension on the nanoscale.
Nanowires
An extremely thin wire with a diameter on the
order of a few nanometers (nm) or less.
Non-degradable Particles
Persistent particles that the body is not able to
break down.
Oxidative Stress
An imbalance between the production of reactive
oxygen and a biological system’s ability to readily
detoxify the reactive intermediates or easily
repair the resulting damage.
Particle Size 
A property affecting the stability, chemical
reactivity, opacity, mobility, and strength of many
materials and determination.
Particle Size Distribution
The distribution or range of particle sizes found
in a given sample. Normally nanoparticle samples
contain a range of particles both larger and
smaller then the mean value, which is often
quoted as the particle size.
Pesticide
A pesticide is any chemical or biological agent
used for control of plant or animal pests.
Pesticides include insecticides, herbicides,
fungicides, nematocides and rodenticides.
PET
Polyethylene terephthalate. A thermoplastic
material used to manufacture plastic soft drink
containers and rigid containers.
Polymer
A substance made of many repeating chemical
units or molecules. The term polymer is often
used in connection with plastic, rubber, or
elastomer.
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Quantum Dot
A quantum dot is a particle of matter so small
that the addition or removal of an electron
changes its properties in some useful way, e.g. it
might glow under UV light.
RDA
Recommended daily (or dietary) allowance, the
quantity of a particular nutrient which should be
consumed daily in order to maintain good health.
Reactive oxygen species (ROS)
Molecules which are highly reactive due to the
presence of unpaired valence shell electrons,
includes oxygen ions, free radicals and peroxides.
Safe Upper Level (SUL)
The upper amount of any particular nutrient that
a person could safely take for a lifetime.
Sensor
[Nanoscale] chemical, biological or physical
sensory points or system used to detect and
convey information about a given environment,
e.g. temperature, pH, location, or the presence of
diseased tissue.
Solubility
A term describing whether nanoparticles
dissolve in water and biological fluids, a property
crucial in assessing the biological impacts of the
particle.
Submucosa
The layer of loose connective tissue that
supports the mucosa and joins it to the bulk of
underlying smooth muscle.
Surface Area 
The surface to volume ratio of a particle or other
body. As the size of a particle decreases more
molecules are present at the surface, giving rise
to a larger surface to volume ratio or larger
surface area for chemical interaction.
Surface Charge
The electric charge present at an interface, for
instance on the surface of a protein in water.The
surface charge influences adsorption process at
the particle’s surface.
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APPENDIX IV: PHYSICAL AND CHEMICAL TECHNIQUES 
FOR CHARACTERISING NANOPARTICLES
Technique Property to be Measured
Rheology Elasticity, viscosity, shear, strain 
Dynamic light scattering (DLS) photon Particle size, distribution, aggregation and
correlation spectroscopy (PCS) hydrodynamic radius, zeta potential
Size exclusion chromatography Molecular weight, hydrodynamic properties 
Absorption spectroscopy Electronic nature of material 
Fourier transform infrared Vibrational energies and composition chemical
spectroscopy – FTIR identification
Luminescence spectroscopy Defects and impurities in samples 
(electro- photo- etc.)
Cyclic voltammeter, potentiometric Kinetic, thermodynamic and electronic 
and electrochemical techniques parameters, surface charge
Confocal laser scanning microscopy Topography, depth profiling, fluorescent imaging 
N2 Gas adsorption BET surface area, pore size distribution 
Raman spectroscopy and surface Vibrational energies and composition 
enhanced raman (SERS) and chemical identification 
Atomic Force Microscopy – AFM Surface topography and chemistry,
(and associated techniques, Magnetic grain size, electronic properties
Force Microscopy MFM, Chemical 
Force Microscopy CFM etc.)
Transmission Electron Microscopy – TEM Morphology size shape crystallographic
structure 
Scanning Electron Microscopy – SEM Topography, morphology, size distribution
Scanning Tunnelling Microscopy – STM 3-D surface topography, size, shape, defects,
electronic structure.
Acoustic attenuation spectroscopy Particle size and distribution agglomeration 
Electroacoustic sonic amplitude – ESA Particle size charge and zeta potential
Doppler micro electrophoresis Particle size charge and zeta potential
Electro acoustic spectroscopy Particle size charge and zeta potential 
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Techniques potentially in used in food sector requiring minimal adaptation for nanoparticles 
Specialised techniques which should be made available to food sector as nanoparticle use
increases 
Highly specialised techniques with reduced relevance to food sector but which could have
occasional needs as nanoparticle use increases 
Technique Property to be Measured
Energy Dispersive Xray Spectroscopy – EDXS Elemental analysis 
Field flow fractionation (FFF) Composite size, molecular weight
hydrodynamic radius 
Nuclear magnetic resonance Identification of structure and ID 
spectroscopy – NMR
Small Angle Neutron and X-Ray Structural information 
Scattering (SANS / SAXS)
X-Ray diffraction (XRD) Crystallographic information 
X-Ray absorption (XRA) Structural information 
Inductively coupled plasma mass Composition and mass
spectrometry (ICP-MS)
Scanning Near Field Optical Chemical specificity, orientation information 
Microscopy – SNOM 
Single molecule spectroscopy – SMS Charge separation, excited states,
and fluorescence efficiencies
Ellipsometry Surface properties, density uniformity and
anisotropy
Electron paramagnetic resonance (EPR) Chemical state, spin orientation 
or electron spin resonance (ESR) determination of G factor, kinetics 
Auger spectroscopy Chemical analysis and composition of surfaces 
X-ray photo electron spectroscopy XPS Chemical analysis of surface 
Mössbauer Chemical structure, and magnetic properties 
Electron energy loss spectroscopy – EELS Chemical composition bonding in crystals 
and at interfaces 
Electron Diffraction Geometry of gaseous molecules
Low Energy Electron Diffraction – LEED Characterisation of surface structures
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APPENDIX V: BIOPHYSICAL AND BIOLOGICAL
TECHNIQUES FOR CHARACTERISING NANOPARTICLES 
IN BIOLOGICAL ENVIRONMENTS
Technique Property to be Measured
Circular dichroism spectroscopy (CD) Secondary and tertiary structure of adsorbed
proteins
Differential scanning calorimetry (DSC) Secondary structure of proteins, protein
stability
Isothermal Titration calorimetry (ITC) Binding isotherms, numbers of proteins bound
per particle
Fourier-transform Infra-red spectroscopy (FTIR) Secondary structure of proteins
Total Internal Reflectance Fluorescence (TIRF) Protein orientation and spreading at surfaces
Enzymatic Assays Catalytic activity of adsorbed proteins
Phage display Libraries Amino acid sequences of peptides with surface
affinities
1D and 2D gel electrophoresis Identification of adsorbed biomolecules
Ellipsometry Amount of bound protein and thickness of
protein layer
Confocal laser scanning microscopy Visualisation of nanoparticle interaction with
cells
Limited proteolysis Fragmentation patterns of proteins, accessible
cleavage sites in adsorbed proteins
Raman spectroscopy and surface Thickness and structural arrangement 
enhanced Raman (SERS) of adsorbed protein layer
Atomic Force Microscopy – AFM
(and associated techniques Magnetic Force Volume and height of adsorbed proteins.
Microscopy MFM, Chemical Force Nanoparticle-cell interactions?
Microscopy CFM etc.)
Immunofluorescence screening Antibody binding to proteins as indicator of
concentration of adsorbed proteins
Electron Microscopy – TEM/SEM Cellular localisation of nanoparticles
Ribonuclease protection assays mRNA transcripts in complex mixture –
cellular response to materials
Real-time polymerase chain reaction (RT-PCR) Gene expression changes – cellular response to
materials
Site-directed mutagenesis Identification of binding site by changing single
residue in protein
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Technique Property to be Measured
Matrix-assisted laser desorption ionization Identification of adsorbed proteins by 
(MALDI) time-of-flight mass spectrometry molecular mass
(ToF-MS)
Time-of-flight secondary ion mass Peptide segments presented at surface 
spectrometry (ToF-SI-MS) of adsorbed layer
Fluorescence Correlation Spectroscopy Dynamics of single molecules 
Quartz crystal microbalance
Nuclear magnetic resonance 
spectroscopy – NMR Identification of structure and ID 
Fluorescence Resonance Energy Transfer (FRET) Extension of proteins upon adsorption,
localisation of nanoparticles intra-cellularly
Small Angle Neutron and X-Ray 3D resolution of shape and arrangement 
Scattering (SANS / SAXS) of adsorbed proteins 
Surface Plasmon Resonance Amount of bound protein,
association/dissociation rates
Techniques potentially in used in food sector requiring minimal adaptation for nanoparticles 
Specialised techniques which should be made available to food sector as nanoparticle use
increases 
Highly specialised techniques with reduced relevance to food sector but which could have
occasional needs as nanoparticle use increases 
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Many of the uses of nanosilver involve embedding the particles into a polymer matrix, or applying it
as a coating, (Marini et al., 2007) meaning that the effects of nanosilver are not surface effects directly,
but rather indirect – the biocidal mechanism of silver-containing products results from a long term
release of silver ions (Ag+) by oxidation of metallic silver (Ag0) in contact with water (Kumar, 2005),
so processing it as nanosilver results in a more efficient release of the silver ions.
In the risk assessment by Blaser et al. the focus is on silver released from nanoparticles embedded in
the polymer with the assumption that only silver ions and not entire nanoparticles are released.The
risk assessment of nanosilver is presented in four stages. First, the system boundaries are defined, mass
flows of silver were quantified, and three emission scenarios were defined. Second, the behavior of
silver in natural freshwater is reviewed, and a mass balance model applied to calculate predicted
environmental concentrations (PECs) for freshwater and freshwater sediments. PECs are also
estimated for sewage treatment plants (STPs) and sewage sludge. The uncertainty of the results is
assessed and predicted concentrations compared to empirical data. Third, toxicity data for
environmentally relevant silver compounds are compiled and predicted no-effect concentrations
(PNECs) determined where possible.
The results of the risk assessment indicate that up to 15% of the total silver emitted into water in
Europe may be released from biocidal plastics and textiles in 2010. Considering that the market for
such products is expected to grow until 2015, it can be concluded that biocidal plastics and textiles
will account for a substantial share of total silver emissions in the future.
APPENDIX VI: RISK ASSESSMENT OF NANOSILVER
CONTAINED IN A POLYMER MATRIX AND POTENTIALLY
RELEASED INTO THE ENVIRONMENT
(Blaser et al. 2008)
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